Introduction {#s1}
============

The evolutionary expansion and elaboration of a gyrated neocortex underlie the complex cognition and development of intellect that characterize primates, especially humans. Emerging evidence suggests that differences in the type, abundance, and mode of division of neural stem and progenitor cells contribute to the diversity in the size and shape of the mammalian neocortex across species ([@bib71]; [@bib88]; [@bib113]; [@bib15]). At the onset of neurogenesis, neuroepithelial cells (neural stem cells) become radial glia. These more committed neural progenitor cells reside in the ventricular zone (VZ) and are referred to as apical radial glia (aRG). Their apical processes are integrated into the ventricular surface while their basal fibers extend radially to the pial basement membrane ([@bib32]). aRG generate neurons directly or indirectly via becoming intermediate progenitor cells (IPC) that occupy the subventricular zone (SVZ). In contrast to their limited proliferation potential in lissencephalic rodents ([@bib22]), IPC undergo multiple rounds of self-renewing division in species with enlarged and folded neocortices ([@bib21]; [@bib36]; [@bib4]; [@bib28]). The increased proliferation of IPC expands the SVZ, which is subdivided into inner and outer compartments in primates ([@bib107]; [@bib131]). The outer SVZ may be responsible for the increased number of upper-layer neurons and thus the tangential expansion of neocortical surface area ([@bib71]; [@bib94]; [@bib95]).

Recent advances in cell labeling and imaging have identified other basal progenitors in addition to IPC. At mid-neurogenesis, some aRG selectively lose their apical processes and move their soma to the outer SVZ ([@bib21]; [@bib36]; [@bib94]; [@bib77]). These newly generated basal radial glia (bRG, also called outer radial glia) are abundantly present in gyrencephalic cortex ([@bib21]; [@bib36]; [@bib94]) but are relatively rare in the lissencephalic mouse cortex ([@bib106]; [@bib121]). It has thus been speculated that bRG expansion is responsible for the emergence and evolution of cortical convolutions ([@bib22]; [@bib71]; [@bib94]; [@bib95]; [@bib29]; [@bib83]; [@bib5]; [@bib15]; [@bib20]). However, the direct link of bRG to cortical gyrification remains unclear because bRG abundance does not correlate with either gyrification or the phylogeny of the neocortex ([@bib26]; [@bib39]; [@bib51]). In mice, genetic manipulations of a number of intrinsic factors ([@bib110]; [@bib25]; [@bib124]; [@bib47]) or signaling pathways ([@bib72]; [@bib91]; [@bib122]) enhance the generation of bRG as well as IPC. In some of these experiments, expansion of these basal progenitors resulted in the folding of the mouse neocortex ([@bib110]; [@bib25]; [@bib124]; [@bib122]), highlighting the importance of bRG and IPC in cortical convolution. Yet little is known about the molecular events that specifically control the transition of aRG into bRG. This information is crucial to our understanding of the molecular basis for the greater abundance of bRG in gyrencephalic than in lissencephalic cortices. It is also important to determine the precise contribution of bRG, relative to IPC, to cortical gyrification.

In amniotes, the folding of the cerebellar cortex results in the formation of an elaborate set of folia similar to neocortical gyri. More extensive folding of the cerebellar cortex correlates with more complex behaviors ([@bib43]; [@bib69]; [@bib34]). From sharks to primates, the cerebellum and neocortex grow regularly and disproportionately to the rest of the brain, with the extent of gyrification reflecting the size of these structures ([@bib128]). These observations suggest that folding of the cerebral and cerebellar cortex is an evolutionary adaptation that allowed the enlargement of brain surface area and thereby the accommodation of more complex functions. Expansion of the granule cell precursors that reside in the external granule layer (EGL) is thought to be the primary driver of cerebellar foliation ([@bib9], [@bib10]; [@bib112]). However, emerging evidence suggests that the interaction between BG and basement membrane is important for cerebellar foliation ([@bib3]; [@bib80]; [@bib93]; [@bib73]). We recently discovered that the deletion of *Ptpn11,* which codes for the protein tyrosine phosphatase Shp2, blocks BG formation and cerebellar foliation, whereas EGL proliferation remains relatively normal in perinatal mouse cerebella ([@bib66]). The expression of a constitutively active Mek1 (Map2k1), Mek1^DD^ ([@bib11]), which specifically activates ERK, rescues both cerebellar foliation and BG generation ([@bib64]), demonstrating the critical role of ERK signaling in BG induction and the essential role of BG in cerebellar foliation. Similar to the cytogenesis of bRG, nascent BG are derived from cerebellar aRG between embryonic day (E) 13.5 and E17.5, again by selectively losing their apical processes and relocating their soma to a basal position (but in this case to the prospective Purkinje cell layer) ([@bib129]; [@bib126]). These nascent BG continue to proliferate until postnatal day (P) seven when they exit the cell cycle and become mature BG ([@bib89]). After their induction, BG express neural stem cell markers, such as Sox2, Sox9, and Tnc through adulthood ([@bib108]; [@bib1]; [@bib52]). The increase and rearrangement of BG basal fibers are associated with dramatic expansion of the cerebellar cortex and fissure formation in perinatal stages ([@bib112]). Several bRG-signature genes, such as *TNC*, *FABP7,* and *PTPRZ1* ([@bib91]; [@bib117]), are also well-known BG markers ([@bib19]; [@bib129]; [@bib114]). These observations raise the question whether the formation of bRG and BG is controlled by related mechanisms involving ERK signaling.

In the current study, we investigated the hypothesis that conserved mechanisms regulate the transition of aRG to BG in the cerebellum, and to bRG in the neocortex. We first established the transcriptomic profile of nascent BG in the mouse cerebellum, and then compared the molecular features of BG to those of human bRG that were recently identified by single-cell RNA sequencing (seq) ([@bib91]; [@bib117]). Given the crucial role of ERK signaling in the aRG-to-BG transition in the mouse cerebellum ([@bib66]), we analyzed and compared the ERK signaling activity in cortical aRG during human and mouse corticogenesis. Finally, we tested whether activation of ERK induced bRG in the mouse neocortex. Our findings demonstrate that BG and bRG not only share similar molecular features, but also related molecular mechanisms in their generation.

Results {#s2}
=======

bRG-specific genes are enriched in BG {#s2-1}
-------------------------------------

Using single-cell RNA-seq, two groups have independently identified specific molecular markers of bRG in human fetal neocortex ([@bib91]; [@bib117]). Using a new computational pipeline ([@bib31]), we identified the consensus signatures for bRG based on the published single-cell RNA-seq datasets ([Figure 1A](#fig1){ref-type="fig"}). Our analysis confirmed most of the reported bRG markers ([@bib91]; [@bib117]) and identified additional ones ([Supplementary file 1A](#SD1-data){ref-type="supplementary-material"}). Inspection of in situ hybridization data of the Allen Mouse Brain Atlas revealed that more than half (51.5%, n = 66) of these bRG-signature gene orthologs were specifically or highly expressed in BG of mouse cerebellum at P56 ([Figure 1B](#fig1){ref-type="fig"}, and [Supplementary file 1B](#SD1-data){ref-type="supplementary-material"}). By contrast, only 2.2% and 4.5% of two randomly selected gene groups were detected in BG (n = 44 and 46, Fisher\'s exact test, p\<0.001, see Method section for details of unbiased expression analysis). Inspection of the Allen Mouse Developmental Brain revealed that many bRG markers appeared to be expressed in BG of the mouse cerebellum at P4 when immature BG were relatively easy to be identified ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). In agreement with RNA in situ hybridization data, immunofluorescence revealed that Hopx, a specific bRG marker ([@bib91]; [@bib117]), was co-localized with the BG marker Fabp7 (also known as BLBP) and Sox2, in the mouse cerebellum at E14.5 and E18.5 ([Figure 1C](#fig1){ref-type="fig"}). As Hopx, Fabp7 and Sox2, like many other BG markers, are also expressed in the VZ, we define BG as those triple labeled cells that have delaminated from the VZ at E14.5 or those reside in the Purkinje cell layer with radial fibers in the molecular layer. Moreover, antibody staining for Hopx and Fabp7 and in situ hybridization for *Etv4*, *Etv5*, *Ptprz1*, *Tnc1*, and *Slc1a3* showed that these bRG markers were absent from the cerebellar cortex of *Ptpn11*-deficient cerebella, where BG generation is blocked ([@bib66]), at E16.5 ([Figure 1---figure supplement 1B and C](#fig1s1){ref-type="fig"}). Collectively, our data suggest that bRG and BG have similar molecular features.10.7554/eLife.23253.003Figure 1.Mouse orthologs of human basal radial glia (bRG)-signature genes are specifically or highly expressed in Bergmann glia (BG) of mouse cerebella.(**A**) Heatmap showing the consensus signature gene sets for apical radial glia (aRG, top bracket to the left) and bRG (lower bracket to the left) in the single-cell RNA-seq datasets of Pollen *et al*. and Thomsen *et al*. Genes of the aRG and bRG gene sets are mostly not expressed in intermediate progenitor cells (IPC). (**B**) In situ hybridization of selected bRG-specific genes in BG of P56 mouse cerebella. The images were generated by the Allen Institute for Brain Science ([@bib61]). (**C**) Immunofluorescent staining of Hopx, Fabp7, and Sox2 shows that Hopx is expressed in BG in E14.5 and E18.5 mouse cerebella. The boxed areas are enlarged and shown in separate channels below; arrowheads point to BG triple-labeled with Hopx, Fabp7, and Sox2. Scale bar: 40 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.003](10.7554/eLife.23253.003)10.7554/eLife.23253.004Figure 1---figure supplement 1.bRG-specific genes are expressed in wild-type but not *Ptpn11-cKO* cerebella.(**A**) In situ hybridization of selected bRG-specific genes in BG of P4 mouse cerebellum. The images were obtained from the Allen Developmental Mouse Brain ([@bib116]). (**B** and **C**). Immunohistochemistry (**B**) and in situ hybridization (**C**) on sagittal sections of E16.5 wild-type and *Ptpn11*-cKO cerebella. The arrows indicate the transcript in presumptive BG in the cerebellar cortex; asterisks show the absence of transcripts; arrowheads denote sporadic Hopx and Fabp7 expression in the ventricular zone.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.004](10.7554/eLife.23253.004)10.7554/eLife.23253.005Figure 1---figure supplement 2.Inspection of gene expression in P56 mouse cerebella.Examples of validation of BG markers based on ISH on sagittal section of P56 mouse cerebella (from Allen Brain Atlas). Arrows indicate the Purkinje cell layer; arrowheads denote signals in radial fibers in the molecular layer. Note that the soma of Purkinje cells are noticeably larger than those of BG.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.005](10.7554/eLife.23253.005)

We next sought to investigate whether nascent BG also have similar molecular features as the human fetal bRG through genome-wide expression analysis. Previous studies have demonstrated that nascent BG are initially formed at E13.5 ([@bib129]), and their generation is blocked by *Ptpn11* deletion but rescued by *Mek1^DD^* expression ([@bib64]). Therefore, we reasoned that the level of BG-enriched transcripts would increase from E12.5 to E14.5 in wild-type (WT) cerebella, decrease in *Ptpn11* conditional knock-out (cKO) cerebella, and become normal in *Ptpn11*-cKO cerebella with *Mek1^DD^* expression (*Ptpn11-cKO;Map2k1*). Through RNA-seq, differentially expressed genes were identified by pairwise comparisons among the cerebella of these three genotypes at E12.5, E13.5, and E14.5 ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). Validation with qPCR and in situ hybridization confirmed the overall accuracy of the RNA-seq data ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). As expected, markers for BG, but not other major cerebellar cell types were significantly decreased in *Ptpn11*-cKO cerebella compared to the control at E13.5 and E14.5 ([Figure 2---figure supplement 2A and B](#fig2s2){ref-type="fig"}). By using an intersection-of-list approach based on the above-mentioned logic, we identified 117 putative BG-specific genes ([Figure 2A](#fig2){ref-type="fig"}), 35.5% of which were apparently expressed in BG in P56 mouse cerebella (Fisher\'s exact test to compare random gene sets, p\<0.001; [Supplementary file 1C](#SD1-data){ref-type="supplementary-material"}) according to Allen Brain Atlas ([@bib61]).10.7554/eLife.23253.006Figure 2.The molecular features of newly generated BG are similar to those of human bRG.(**A**) Identification of BG candidate genes by intersecting significantly up- (red) and down- (blue) regulated genes between different embryonic stages and/or genotypes as indicated. (**B**) Dendrograms showing average linkage hierarchical clustering of genes on the basis of topological overlap. Modules of coexpressed genes are assigned in color blocks, as indicated by the horizontal bar beneath the dendrograms; the second bar shows BG-specific genes, indicated by individual vertical lines; the arrow indicates the aggregation of vertical lines -- enrichment of BG-specific genes -- corresponding to the BG module. (**C**) Boxplots showing module eigengene expression of the BG-module in different genotypes and embryonic stages. \*\*p\<0.01 (ANOVA with a post-hoc Turkey-Kramer multiple comparison test); ns, not significant (p\>0.05). (**D**) Functional enrichment of BG-module hub genes. (**E**) PAGODA analyses of Pollen's (left) and Thomsen's (right) single-cell RNA-seq datasets show that human cortical bRG are significantly enriched for the BG-module genes detected by PAGODA. The question mark indicates an undefined cell type. Adjusted *Z*-scores (a *Z*-score \>1.96 is equivalent to p\<0.05) are shown to the left of the heatmap.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.006](10.7554/eLife.23253.006)10.7554/eLife.23253.007Figure 2---figure supplement 1.Validation of RNA-seq data.(**A**) Correlation between qPCR and RNA-seq data. Pearson correlation test. (**B**) In situ hybridization on sagittal sections of wild-type and *Ptpn11*-cKO cerebella at E14.5. Arrowheads indicate transcripts in the VZ.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.007](10.7554/eLife.23253.007)10.7554/eLife.23253.008Figure 2---figure supplement 2.The loss of *Ptpn11* greatly reduces the expression of BG, but not non-BG, marker genes.(**A and B**) Bar plots of log2 fold changes of molecular markers for different cerebellar cell types at E13.5 (**A**) and E14.5 (**B**). Note that RNA-seq data suggest no significant change in *Slc1a3*, a known BG marker, in agreement with our ISH data that show abundant *Slc1a3* transcripts in aRG in *Ptpn11-cKO* cerebella ([Figure 2--- figure supplementary 1B](#fig2s1){ref-type="fig"}). Furthermore, the slight increase in the mRNA of *Atoh1* and *Pax6* in *Ptpn11*-cKO cerebella at E14.5 compared to the control are in agreement with the thickened EGL found in *Ptpn11*-cKO mutants as described previously ([@bib66]). (**C and D**) Gene set enrichment analysis plot (**C**) and heatmap (**D**) show the significant downregulation of mouse homologues of human bRG markers in *Ptpn11*-cKO cerebella at E13.5 and E14.5 compared to the control. The color blocks in the horizontal bar beneath the dendrograms indicate the sample genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.008](10.7554/eLife.23253.008)

Because the intersection-of-list approach is difficult to control for a type I error ([@bib82]), we conducted an unsupervised weighted gene coexpression network analysis (WGCNA). WGCNA can elucidate the higher-order relationships between genes based on their coexpression relationships and thus allows the delineation of modules -- groups of genes with highly correlated expression patterns, which represent biologically related genes or cell-type-specific markers ([@bib85]; [@bib72]). A coexpression module that was enriched for the 117 BG-specific genes was identified ([Figure 2B](#fig2){ref-type="fig"}). In agreement with our prediction, the BG-module eigengene values, which summarize the overall expression profile of genes in a module (the first principal component) ([@bib56]), gradually increased from E12.5 to E14.5, was significantly lower in *Ptpn11*-cKO cerebella than the control at each stage, and became comparable between *Ptpn11*-cKO; *Map2k1* and WT cerebella ([Figure 2C](#fig2){ref-type="fig"}). BG-module hub genes (those most highly connected within the module) were enriched for functions in stem cell development and Map2k1-ERK signaling ([Figure 2D](#fig2){ref-type="fig"}), in agreement with the critical role of this signaling pathway in the generation of BG as presumptive neural progenitors in the cerebellum. 98 of the 117 BG-specific genes identified by the intersection-of-list approach were included in the 334 BG-module hub genes, suggesting that WGCNA discovers additional BG-enriched genes that are missed by the intersection-of-list method. Indeed, we identified additional 29 genes that are apparently expressed in BG at P56 according to the Allen Mouse Brain ([Supplementary file 1D](#SD1-data){ref-type="supplementary-material"}).

We then compare the high-confidence BG-specific genes with bRG-signature markers with three statistical methods. Hypergeometric distribution revealed significantly overlap between BG module hub genes and bRG markers (p=1.39 × 10^−7^). Moreover, gene set enrichment analysis ([@bib111]) showed that bRG marker genes were significantly down-regulated in *Ptpn11*-cKO cerebella at E13.5 ([Figure 2---figure supplement 1C and D](#fig2s1){ref-type="fig"}). Finally, a pathway and gene set over dispersion analysis (PAGODA) was performed on the single-cell RNA-seq datasets ([@bib91]; [@bib117]) using extensive gene sets, including the newly identified putative BG and bRG markers, to identify cells that exhibit a statistically significant excess of coordinated variability ([@bib18]). Notably, both the consensus bRG signature gene ([Figure 1A](#fig1){ref-type="fig"}) and BG-specific gene sets identified the same population of human cortical progenitor cells (presumably bRG, [Figure 2E](#fig2){ref-type="fig"}). Collectively, these data show that the gene expression signatures of neocortical bRG and nascent murine BG are remarkably similar.

Stronger FGF-ERK signaling activity in human than mouse neocortical aRG {#s2-2}
-----------------------------------------------------------------------

We also identified 15 human cortical aRG-specific markers based on the published single-cell RNA-seq datasets ([Figure 1A](#fig1){ref-type="fig"} and [Supplementary file 1A](#SD1-data){ref-type="supplementary-material"}). Among them, *FOS* and *EGR1,* two early-response targets of FGF-ERK signaling ([@bib48]), are expressed in human but not mouse aRG ([@bib90]). To identify ERK early-response gene, we mined published microarray data profiling the transcriptional responses to ERK activation in mouse embryonic stem cells ([@bib35]). We identified genes that were significantly up-regulated (at least 2-fold; adjusted p\<0.05) within 4 hr after ERK activation ([Supplementary file 3](#SD3-data){ref-type="supplementary-material"}). Out of the 15 aRG-specific markers, seven genes, *EGR1*, *FOS*, *ANXA1*, *CLU*, *CRYAB*, *CYR61*, and *FBXO32,* were among the early-response genes induced by ERK signaling ([Figure 3A](#fig3){ref-type="fig"}). Remarkably, orthologs of these human aRG-specific genes, with the exception of *Cy61* and *Clu*, were transcriptionally silent in the VZ of mouse neocortex at E14.5 ([Figure 3B](#fig3){ref-type="fig"}). These data suggest the presence of robust ERK signaling activity in human, but not mouse, aRG during mid-neurogenesis of the developing cortex.10.7554/eLife.23253.009Figure 3.Heightened ERK signaling activity in human aRG.(**A**) Line-graph showing the fold increases (log~2~ scale) in ERK-responding genes between time zero and the indicated time points after ERK activation, based on a microarray time course analysis ([@bib35]). The fold changes above the dashed line are statistically significant (adjusted p\<0.05). (**B**) In situ hybridization of mouse cortical sections at E14.5. Images were obtained from GenePaint ([@bib119]). (**C**) Principal component plot showing the relationship among samples: GSE30765 ([@bib2]), GSE38805 ([@bib23]), GSE65000 ([@bib25]), and GSE66217 ([@bib45]). (**D**) RNA-seq analysis of FGF-ERK read-out genes in aRG from human and mouse neocortex. \*\*p\<0.005; \*\*\*p\<0.001; ns, not significant. (**E**) Gene Set Enrichment Analysis plot shows the significant enrichment of early-response (within 2 hr) genes induced by ERK activation in human versus mouse aRG. (**F**) Preservation of pathways and gene sets in human and mouse cortical coexpression networks. The blue and red dashed lines indicate Zsummary at 2 and 10, which are the cutoff for not significant and highly significant, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.009](10.7554/eLife.23253.009)10.7554/eLife.23253.010Figure 3---figure supplement 1.Comparison of gene expression in aRG/VZ between human and mouse neocortex.(**A**) Heatmap showing the relationship among samples, GSE30765 ([@bib2]), GSE38805 ([@bib23]), GSE65000 ([@bib25]), and GSE66217 ([@bib45]), as calculated from the variance stabilizing transformation of the gene counts. (**B**) Scatterplot of ranked average gene expression between human and mouse. (**C**) MAplot showing log2 fold changes attributable to a given variable over the mean of normalized counts. Red points indicate the adjusted p\<0.05, triangles indicate points outside the range. (**D**) Histogram of *p* value distribution. Note the anti-conservative *p* value distribution as expected. (**E**) Barplots showing human versus mouse fold changes (log~2~) in levels of pan radial glial markers identified previously ([@bib72]).**DOI:** [http://dx.doi.org/10.7554/eLife.23253.010](10.7554/eLife.23253.010)

To systematically compare FGF-ERK signaling activities in the neocortical aRG between humans and mice, we performed differential expression analyses based on six published RNA-seq datasets generated from laser-capture microdissected VZ ([@bib2]; [@bib23]) or sorted aRG ([@bib25]; [@bib45]). Among the 21 E14.5 mouse and 13 GW13--18 human aRG samples included in these independent studies, there was a close similarity among samples of the same species ([Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). On the other hand, there was a significant positive correlation (Spearman\'s rank correlation coefficient *R* = 0.85, p=1 × 10^−200^) between the mean expression levels in mouse and human aRG ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), demonstrating the compatibility of the mouse and human datasets. The percentages of up and down regulated genes in the human and mouse samples were similar ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Across a panel (n = 56) of pan-aRG markers ([@bib72]), 37.9% were up-regulated (17.3% down) in human aRG whereas 44.8% were unchanged ([Figure 3D](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). Collectively, these results demonstrated the absence of systematic bias between the two species in gene expression measurements by RNA-seq. The mRNA levels of FGF-readout genes (*SPRY1, SPRY2, SPRY4,* and *ETV5*) and of all seven ERK early-response genes were significantly higher in humans than those in mice ([Figure 3D](#fig3){ref-type="fig"}). In agreement with a recent report ([@bib122]), the hedgehog readout gene *Gli1* (but not *Ptch1*) was moderately increased in human versus mouse aRG ([Figure 3D](#fig3){ref-type="fig"}). To analyze pathways differentially enriched in either human or mouse aRG, we performed a gene set enrichment analysis (GSEA) ([@bib111]). In agreement with earlier findings ([@bib23]; [@bib25]), GSEA showed that the gene sets significantly enriched in human aRG contain genes encoding hallmarks of epithelial-mesenchymal transition, extracellular matrix components, extracellular matrix receptors, and integrin signaling, whereas those enriched in mouse aRG are involved in transcription, translation, DNA replication, and the citric acid cycle ([Supplementary file 4A](#SD4-data){ref-type="supplementary-material"}). Among the most highly enriched genes in human aRG were early-response genes induced by ERK (NES = 2.06, FDR = 0.001) and BG-module genes (NES = 1.91, FDR = 0.01) ([Figure 3E](#fig3){ref-type="fig"} and [Supplementary file 4A](#SD4-data){ref-type="supplementary-material"}). These findings indicate elevated FGF-ERK signaling activity in human cortical aRG compared to the mouse cortical aRG.

To further study the difference between mouse and human corticogenesis, we used a complementary approach in which the higher-order relationships between genes were compared based on their coexpression relationships in separate human and mouse networks. Changes in network position between species can reveal divergent regulation or a novel function that contributes to human-specific phenotypes ([@bib84]; [@bib79]; [@bib72]). We used WGCNA, which had been extensively applied to compare corticogenesis across species ([@bib84]; [@bib79]; [@bib53]; [@bib72]) and under pathological conditions ([@bib41]; [@bib7]; [@bib86]; [@bib105]), to study the preservation of signaling pathways (KEGG and Reactome), pan-RG signature genes ([@bib72]), early-response genes induced by ERK, and signature genes for aRG, bRG, and IPC ([Figure 1A](#fig1){ref-type="fig"}). As expected, the strongly preserved gene sets (Zsummary sore \>10) were those related to pan-aRG, IPC, and cell cycle ([Figure 3F](#fig3){ref-type="fig"}). Of note, the gene sets related to aRG, ERK-early-response genes, FGF and BMP signaling pathway were weakly preserved between the human and mouse coexpression networks ([Figure 3F](#fig3){ref-type="fig"}). This suggests that the transcriptional regulation of aRG and FGF-ERK pathway genes greatly differs between human and mouse corticogenesis.

Formation of bRG correlates with intensified ERK signaling activity {#s2-3}
-------------------------------------------------------------------

To corroborate our bioinformatic analysis, we performed immunohistochemistry of human and mouse embryonic cortices using an anti-phospho-ERK (pERK) antibody that detects both phosphorylated ERK1 and ERK2. We detected robust pERK immunoreactivity in the soma and radial fibers of radial glia marked by Pax6 in the VZ and outer SVZ of human fetal brain gestation week (GW) 19, when bRG are present in abundance ([@bib36]; [@bib91])([Figure 4A and B](#fig4){ref-type="fig"}). Furthermore, abundant pERK/HOPX double-labeled cells were found in the outer SVZ ([Figure 4A and C](#fig4){ref-type="fig"}). In mouse embryonic brains, in contrast to the strong pERK immunoreactivity seen in the VZ of the ventral telencephalon, ventral mid-hindbrain, and cerebellum, only weak and diffuse pERK signals were detected in the dorsal telencephalon between E13.5 and E16.5 ([Figure 4D and F](#fig4){ref-type="fig"}). The cortical pERK expression pattern was similar to that described in the previous publications ([@bib17]; [@bib92]). Remarkably, by E17.5 strong pERK signal was detected in aRG and some basally located cells in the neocortex ([Figure 4E and F](#fig4){ref-type="fig"}). Although weak Hopx expression was detected in the VZ in the E16.5 cortex, few Hopx-positive (Hopx^+^) cells were found in the SVZ until E17.5 ([Figure 4G,H](#fig4){ref-type="fig"}, and data not shown). Between E17.5 and E18.5, scattered Hopx^+^ cells were present in the SVZ and cortical plate; the colocalization for Fabp7 and Sox2 ([Figure 4G](#fig4){ref-type="fig"}) suggested that these cells were mouse bRG. Notably, pERK and Hopx colocalized in basally located cells, with about half of them displaying unipolar processes that were extending to the pial basement membrane (unipolar, 50.21 ± 4.76%; bipolar, 7.55 ± 9.67%; the rest were ambiguous or multipolar; n = 1,246; [Figure 4H and I](#fig4){ref-type="fig"}). Our data suggest that the development of presumptive bRG correlates closely with ERK signaling in both human and mouse cortex, albeit the delayed appearance and reduced number of bRG in the mouse neocortex.10.7554/eLife.23253.011Figure 4.Activation of ERK signaling is associated with bRG formation.(**A--H**) Immunofluorescence on sections of human (A--C, 19 gestational week) and mouse (D--H) fetal brains. Arrowheads indicate the regions that are enlarged in B and C and show pERK immunoreactivity in Pax6-positive aRG (**B**) and Hopx/Sox2 doubled-labeled bRG (**C**); the boxed areas in D are enlarged in the inset; the dashed line demarcates the ventricle; arrowheads point to robust pERK staining in the ventricular zone (VZ); the unfilled arrowhead in E indicates the area enlarged in G and H. Note that pERK signals are increased at the apical surface of VZ from E16.5 to E17.5 (**F**). Arrows indicate Hopx/Fabp7/Sox2 triple-positive cells (**G**) and Hopx/pERK double-labeled cells (**H**) on E18.5 cortical sections. Nuclei are stained with Hoechst 33342. (**I**) Bar charts showing the percentage of Hopx/pERK double-labeled cells relative to the total number of counted pERK (n = 642) or Hopx (n = 488) cells. Abbreviations: cp, cortical plate; ISVZ, inner subventricular zone; OSVZ, outer subventricular zone; Pia, pial surface; SP, cortical subplate. Scale bars: 20 µm (**B, C, G, H and F**), 200 µm (**D**), and 100 µm (**E**).**DOI:** [http://dx.doi.org/10.7554/eLife.23253.011](10.7554/eLife.23253.011)

Hyperactivation of ERK signaling induces bRG in the murine neocortex {#s2-4}
--------------------------------------------------------------------

The function of the ERK pathway in bRG formation was tested by expressing the ERK activator *Mek1^DD^* in the E14.5 mouse cortex through *in utero* electroporation ([@bib103]). The electroporation of GFP had little effect on the expression of bRG markers; however, bRG markers including Hopx, Fabp7, *Tnc*, *Slc1a3*, and *Ptprz1* were robustly induced following the electroporation of *Mek1^DD^* 48 hr after electroporation ([Figure 5A--C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, and [Video 1](#media1){ref-type="other"}). As reported previously ([@bib75]), electroporation occasionally caused the basal dispersion of aRG in the VZ ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), but only a small fraction of the dispersed GFP-expressing cells (3.3 ± 1.5%) expressed Hopx, whereas 31.8 ± 4.7% of the *Mek1^DD^*-expressing cells (marked by GFP) simultaneously expressed Hopx and Sox2 at 48 hr after electroporation ([Figure 5B,C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, and [Video 1](#media1){ref-type="other"}). This showed that Mek1^DD^ cell-autonomously induces bRG-like cells. Similar to the characteristic morphology of bRG in primate cortices ([@bib21]; [@bib36]; [@bib94]; [@bib51]; [@bib4]; [@bib28]), the *Mek1^DD^*-expressing cells that expressed bRG markers displayed long basal processes that reached the pial surface (78.2 ± 3.1%, n = 384) and occasionally also an apical process (21.8 ± 3.1%; [Figure 5C](#fig5){ref-type="fig"} and [Video 1](#media1){ref-type="other"}). In agreement with previous reports of an association between bRG and persistent *Pax6* expression ([@bib23]; [@bib124]), 57.4 ± 3.8% of the *Mek1^DD^*-expressing cells were positive for Pax6 (n = 1787 cells counted) in 48--96 hr after electroporation ([Figure 5D](#fig5){ref-type="fig"}). Notably, only 5.24 ± 1.75% *Mek1^DD^*-expressing cells were positive for the IPC marker Eomes (n = 1,083; [Figure 5E](#fig5){ref-type="fig"}). Collectively, our data show that *Mek1^DD^* expression induces bRG, but not IPC, in the mouse neocortex.10.7554/eLife.23253.012Figure 5.Hyperactivation of ERK signaling induces bRG in the mouse neocortex.(**A**) Schematic of the electroporation experiment. The box with the dotted lines indicates the approximate cortical area shown in the rest of the figure. (**B--E**) Immunofluorescence and in situ hybridization images of adjacent coronal sections of mouse cortices 48 hr (B, C, and E) and 96 hr (**D**) after the *in utero* electroporation of the indicated transgene. The thin dotted lines demarcate the pial surface; and the thick dotted lines separate the areas with and without electroporated cells; asterisks indicate the induction of bRG; the arrowheads in D indicate the heterotopia above the VZ; the inset in B is a low-magnification image showing *Tnc* expression in the cortical VZ on both the transfected and untransfected sides. A three-dimensional rendering of the induced bRG is shown in [Video 1](#media1){ref-type="other"}. Nuclei are stained with Hoechst 33342. Scale bars: 200 µm (**B**), 20 µm (C--E).**DOI:** [http://dx.doi.org/10.7554/eLife.23253.012](10.7554/eLife.23253.012)10.7554/eLife.23253.013Figure 5---figure supplement 1.*Mek1^D^*^D^-induced bRG form heterotopia in the lower layer of the cortex.Immunofluorescence on coronal section of mouse cortices at E16.5, P3, and P7 as indicated after *in uter*o electroporation at E14.5. The dashed line demarcates the ventricular surface; arrowheads indicate the cluster of *Mek1^DD^*-transfected cells in the lower layer of the cortex; the arrow shows that a cluster of Sabt2+ neurons derived from *Mek1^DD^-*transfected cells. Note that *Mek1^DD^*-transfected cells in the heterotopia mostly express Sabt2 but not Gfap. Scale bars: 40 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.013](10.7554/eLife.23253.013)10.7554/eLife.23253.014Figure 5---figure supplement 2.Electroporation of *EGFP* does not induce bRG.Immunofluorescence on coronal sections of E16.5 neocortex following *in utero* electroporation of EGFP at E14.5. The boxed area is enlarged; the dashed line outlines the pial surface. Arrows indicate the perturbed VZ due to electroporation. Arrowheads show bRG that are positive for Hopx and Sox2, but lack GFP expression.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.014](10.7554/eLife.23253.014)Video 1.Movie of three-dimension rendering of *Mek1^DD^*-induced bRG in the mouse cortex.The red, green and blue channels represent antibody-staining for Hopx, GFP, and Sox2, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.015](10.7554/eLife.23253.015)10.7554/eLife.23253.015

Induced bRG undergo multiple rounds of self-renewing proliferation and give rise to upper-layer neurons {#s2-5}
-------------------------------------------------------------------------------------------------------

The proliferation and differentiation potential of the induced bRG in the mouse neocortex was studied using immunofluorescence. 48 hr after electroporation, most *Mek1^DD^*-induced Hopx^+^ cells were positive for Ki67 and a fraction of them was also positive for phospho-vimentin (pVim), a marker of M-phase cells ([Figure 6A](#fig6){ref-type="fig"}). This result demonstrated that most *Mek1^DD^*-induced bRG were highly proliferative. To determine whether the induced bRG were capable to undergo multiple rounds of self-renewing divisions, a hallmark of basal progenitors in primate neocortex, embryos were electroporated at E14.5 and then treated with the thymidine analogues 5-bromodeoxyuridine (BrdU) and 5-ethynyldeoxyuridine (EdU) at E16.5 and E17.5, respectively ([Figure 6B](#fig6){ref-type="fig"}). In embryos electroporated with GFP, few GFP^+^ cells were co-labeled with BrdU, EdU, or Ki67 at E18.5 (type 4 cells, [Figure 6B and C](#fig6){ref-type="fig"}). By contrast, most *Mek1^DD^*-expressing cells were positive for at least two of the three labeling at E18.5 (types 1 and 2 cells, [Figure 6B and C](#fig6){ref-type="fig"}), consistent with their having undergone at least two rounds of divisions and/or continuing to divide 96 hr after electroporation. The latter conclusion was supported by the notably weakened GFP immunoreactivity in BrdU^+^/EdU^+^ cells ([Figure 6C](#fig6){ref-type="fig"}). Moreover, the clustering of *Mek1^DD^*--expressing cells that were positive for Hopx, BrdU, and EdU between the SVZ and cortical plate ([Figure 6D](#fig6){ref-type="fig"}) suggested that Mek1^DD^ induced bRG underwent clonal expansion and extensive self renewal.10.7554/eLife.23253.016Figure 6.*Mek1^DD^*-induced bRG undergo multiple rounds of self-renewing divisions.(**A**) Immunofluorescence of phosphorylated vimentin (pVim), GFP, and Ki67 on coronal sections of E14.5 mouse cortex 48 hr after their electroporation. Dashed lines demarcate the pial surface; arrowheads indicate pVim-positive transfected cells (marked by GFP); arrows indicate a doublet of bRG at the end of mitosis. (**B**) Illustrations showing the boxed area that is corresponding to the images in this figure (upper) and the protocol used to study the proliferation of transfected cells (lower). BrdU/EdU/Ki67 triple labeling identifies four types of cells with distinct proliferation history. (**C and D**) Immunofluorescence on coronal sections of E18.5 mouse cortex electroporated *in utero* with *EGFP* or *Mek1^DD^* at E14.5. The boxed areas are enlarged and shown in individual channels. Arrowheads denote clusters of *Mek1^DD^*-transfected cells (**C**) and the induced Hopx-positive cells (**D**), which are mostly BrdU/EdU double (type 2) and BrdU/EdU/Ki67 triple (type 1) positive. (**E**) Illustration of the cell-pair assay procedure. The red dashed line indicates separation of the upper and lower parts of the cortex transfected with *Mek1^DD^*. (**F**) Immunocytochemistry of transfected cells (GFP^+^) and daughter-cell pairs. (**G**) Quantification of the percentage of transfected cells marked by GFP that underwent different modes of divisions. *P* values were calculated using a χ^2^ test. Scale bars: 20 µm (**A**), 200 µm (**C**), 50 µm (**D**), and 5 µm (**F**).**DOI:** [http://dx.doi.org/10.7554/eLife.23253.016](10.7554/eLife.23253.016)

To examine the mode of cell division of the induced bRG, we conducted clonal cell-pair assays ([Figure 6E](#fig6){ref-type="fig"}). This method has been extensively used to analyze symmetric versus asymmetric cell division in neural progenitor cells ([@bib102]). We found that in transfected cells isolated from the cortex 48 hr after electroporation most *Mek1^DD^*-expressing cells underwent symmetric division to generate two Fabp7^+^ daughter cells (data not shown). At 72 hr after electroporation, all three possible cell division types were present among the GFP^+^ *Mek1^DD^*-expressing doublets: bRG-bRG (Fabp7-Fabp7), bRG-neuron (Fabp7-Tubb3), and neuron-neuron (Tubb3-Tubb3) ([Figure 6F and G](#fig6){ref-type="fig"}). Most of the *Mek1^DD^*-expressing doublets underwent proliferative division (Fabp7-Fabp7) either from the upper (80.0%) or the lower (70.2%, including the SVZ and VZ) part of the cortex, in contrast to the predominantly neurogenic division (Tubb3-Tubb3, 64.5%) of the GFP-only-expressing doublets ([Figure 6G](#fig6){ref-type="fig"}). Collectively, our data show that expression of Mek1^DD^ induces bRG-like cells that have extensive self-renewing and neurogenic potential.

To follow the fate of the induced bRG, markers of cortical neurons were examined in P3 cortices. In brains transfected with GFP alone, GFP^+^ cells were arranged uniformly in the upper layer and expressed Satb2 (layer II-IV neurons), but not the deep-layer neuronal markers Tbr1 and Ctip2 ([Figure 7A](#fig7){ref-type="fig"} and data not shown). Many *Mek1^DD^*-transfected cells with strong GFP also expressed Satb2 but they were arranged instead in clusters ([Figure 7A](#fig7){ref-type="fig"}), in agreement with the clonal expansion of the induced bRG observed at the earlier stages and the subsequent formation of Satb2^+^ cells from the bRG. Although increased numbers of astrocytes marked by Gfap were detected in the area containing *Mek1^DD^*-transfected cells compared to non-transfected area ([Figure 7A and B](#fig7){ref-type="fig"}), GFP-labeled *Mek1^DD^*-tranfected cells in the P3 neocortex were mostly devoid of Gfap and the oligoglial markers Olig2 and Sox10 ([Figure 7B](#fig7){ref-type="fig"} and data not shown). At P7, however, some *Mek1^DD^*-expressing cells with low-level GFP expression were positive for Gfap ([Figure 7C](#fig7){ref-type="fig"}), suggesting that the induced bRG are multipotent. Despite the ectopic bRG induction, *in utero* electroporation of *Mek1^DD^* did not cause folding of the cortex (n = 10). Together, our data show that *Mek1^DD^*-induced bRG have extensive proliferation capacity and give rise to both neurons and astrocytes. However, at least to the extent of increased number of bRG obtained with the electroporation folding of the mouse cortex is not induced by expansion of bRG in the absence of parallel expansion of IPCs.10.7554/eLife.23253.017Figure 7.*Mek1^DD^*-induced bRG form neurons and astrocytes.(**A**) Immunofluorescence of Satb2, GFP, and Gfap on coronal sections of mouse cortex 8 days after electroporation. The bracket indicates layers of Satb2-positive neurons derived from GFP-transfected cells; the arrows show clusters of Satb2-positive neurons formed by *Mek1^DD^*-transfected cells; the asterisk denotes the accumulation of astrocytes; arrowheads indicate scattered *Mek1^DD^* -transfected cells with weak GFP and negative for Gfap. (**B and C**) Immunofluorescence of Gfap and GFP on coronal sections of P3 (**B**) and P7 (**C**) brains electroporated at E14.5. Arrowheads and arrows point to absence and presence, respectively, of GFP in Gfap+ cells. Nuclei were stained with Hoechst 33342 and are shown in the blue channel.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.017](10.7554/eLife.23253.017)

Induction of bRG and BG is similarly regulated by an FGF-ERK-ETV axis {#s2-6}
---------------------------------------------------------------------

We found that *ETV5* and, to a lesser degree, *Etv4* were increased in human cortical aRG compared to mouse aRG ([Figure 3C](#fig3){ref-type="fig"}). Etv4 and Etv5 are well-known effectors of the FGF-Ras-ERK signaling cascade ([@bib76]; [@bib133]; [@bib40]; [@bib65]; [@bib6]). Moreover, *ETV5* is specifically expressed in bRG among human cortical progenitor cells ([@bib91]; [@bib117]). Finally, the transcripts of *Etv4* and *Etv5* were missing in *Ptpn11*-cKO cerebella but were restored in *Ptpn11-*cKO*;Map2k1* cerebella at E14.5 ([Figure 8A](#fig8){ref-type="fig"}). These observations raised the question if an FGF-ERK-ETV cascade is involved in the genesis of bRG and BG.10.7554/eLife.23253.018Figure 8.Etv4 and Etv5 are important for BG formation.(**A**) In situ hybridization for *Etv4* and *Etv5* on sagittal sections of E14.5 cerebella. The presence and absence of *Etv4* and *Etv5* transcripts are indicated by arrows and arrowheads, respectively. (**B and C**) Immunofluorescence on sagittal sections of E16.5 *Gbx2^+/creER^;R26^RFP/+^* (**B**) and *Gbx2^+/creER^;R26^Etv4DN/+^* cerebella (**C**) treated with tamoxifen at E9.5. (**D**) Quantification of *RFP* and *Etv4^DN^*-expressing cells that display Fabp7 immunoreactivity in combined (all) or individual areas 1--3, as indicated in the illustration in the lower right corner. Unpaired Student's t-test, p=0.008268, *t~(~*~4)~ = 8.059 (all); p=0.004507, *t~(~*~4)~ = 5.760 (area 1); p=0.006968, *t~(~*~4)~ = 5.103 (area 2); p=0.01634, *t~(~*~4)~ = 3.985 (area 3).**DOI:** [http://dx.doi.org/10.7554/eLife.23253.018](10.7554/eLife.23253.018)10.7554/eLife.23253.019Figure 8---figure supplement 1.Contribution of *Gbx2*-expressing cells at E9.5 to different cerebellar cell types.Immunofluorescence on sagittal sections of E16.5 *Gbx2^+/creER^;R26^RFP/+^* cerebella treated with tamoxifen at E9.5. Arrows indicate that colocalization of RFP and different cerebellar markers, Calb1 (marking Purkinje cells), Pax2 (GABAergic interneurons), and Pax6 (granule cell precursors).**DOI:** [http://dx.doi.org/10.7554/eLife.23253.019](10.7554/eLife.23253.019)10.7554/eLife.23253.020Figure 8---figure supplement 2.Inactivation of Etv4 and Etv5 does not affect the activation of ERK, neurogenesis, or cell survival.(**A and B**) Immunofluorescence of GFP together with pERK (**A**) or Olig2 (**B**) on sagittal sections of E13.5 *Gbx2^+/creER^;R26^Etv4DN/+^* embryos treated with tamoxifen at E9.5. Arrowheads point to pERK and Olig2 immunoreactivity in GFP^+^ *Etv4^DN^*-expressing cells; the bracket demarcates the VZ. (**C**) Immunofluorescence of activated caspase three on sagittal cerebellar sections of E16.5 wild-type and *Gbx2^+/creER^;R26^Etv4DN/+^* embryos treated with tamoxifen at E9.5. The few Casp3+ cells are indicated by arrows. Note that the Casp3 is not colocalized with GFP, which marks *Etv4^DN^*-expressing cells.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.020](10.7554/eLife.23253.020)10.7554/eLife.23253.021Figure 8---figure supplement 3.Simultaneous deletion of *Fgfr1*, *Fgfr2*, and *Fgfr3* results in the similar phenotype as that found in *Ptpn11*-cKO mice.Immunofluorescence for Gfap on sagittal sections P25 cerebellum of indicated genotypes. The boxes indicate the area that is enlarged in the lower panel; the arrow and asterisk show the presence and absence, respectively, of the parallel radial fibers of BG in the molecular layer. The nuclei were stained with Hoechst 33342.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.021](10.7554/eLife.23253.021)

To test this hypothesis, we first investigate the role of *Etv4* and *Etv5* in BG formation. Through tamoxifen-induced Cre-mediated recombination in *Gbx2^creER/+^;R26^Etv4DN/+^* embryos at E9.5, we expressed a dominant negative Etv4 (Etv4^DN^), a fusion between the Etv4 DNA-binding domain and the engrailed repressor domain ([@bib76]), to block the redundant function of *Etv4* and *Etv5* in cerebellar aRG and their progeny. Fate-mapping study using a tdTomato red fluorescent protein (RFP) reporter *R26^RFP^* mouse line ([@bib74]), we found that the *Gbx2*-expressing cells at E9.5 gave rise to BG, Purkinje cells, GABAergic interneurons, and granule cell precursors ([Figure 8B](#fig8){ref-type="fig"} and [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Compared to cells that expressed RFP in *Gbx2^creER/+^;R26^RFP/+^* embryos, significantly fewer Etv4^DN^-expressing cells (marked by GFP) formed BG ([Figure 8B--D](#fig8){ref-type="fig"}). pERK immunoreactivity was detected in *Etv4^DN^*-expressing cells in the cerebellar VZ at E13.5 ([Figure 8---figure supplement 2A](#fig8s2){ref-type="fig"}), indicating that ERK signaling acts upstream of Etv4 and Etv5. No difference in the expression of Olig2 (cerebellar GABAergic precursors) ([@bib101]; [@bib46]) was detected between *Etv4^DN^*-positive and *Etv4^DN^-*negative cells inside or near the cerebellar VZ in E13.5 *Gbx2^creER/+^;R26^Etv4DN/+^* embryos ([Figure 8---figure supplement 2B](#fig8s2){ref-type="fig"}), suggesting that *Etv4^DN^* expression does not overtly alter neurogenesis from cerebellar aRG. Finally, we ruled out that Etv4^DN^ caused cell death of developing BG by immunohistochemistry for activated caspase 3 ([Figure 8---figure supplement 2C](#fig8s2){ref-type="fig"}). Collectively, our data suggest that *Etv4* and *Etv5* are essential for BG formation.

Whether the forced expression of *Etv4* or *Etv5* restores BG in *Ptpn11*-cKO cerebella was investigated in a novel ex vivo electroporation procedure ([Figure 9A](#fig9){ref-type="fig"}). With this procedure, only cerebellar aRG, which line the ventricular zone surface and contact with DNA solution injected into the fourth ventricle, are transfected. In WT cerebellar slices after 24 or 48 hr of in vitro culture, aRG transfected with GFP formed BG, which were identified by markers (Fabp7 and Sox9) and the unipolar morphology of the cells, and non-BG cells ([Figure 9B](#fig9){ref-type="fig"}). In *Ptpn11*-cKO cerebellar slices, GFP-transfected cells were mostly restricted to the VZ, displaying long basal processes and immunoreactivity for Sox9 but not Fabp7 ([Figure 9B](#fig9){ref-type="fig"}). This result demonstrated that the inactivation of *Ptpn11* blocks the aRG-to-BG transition, as previously described ([@bib66]). Remarkably, electroporation of *Mek1^DD^* robustly rescued BG in *Ptpn11*-cKO cerebella ([Figure 9C](#fig9){ref-type="fig"}). Electroporation of *Etv4* or *Etv5* also rescued the formation of BG but to less extent compared to that of *Mek1^DD^* ([Figure 9D](#fig9){ref-type="fig"} and data not shown). The BG marker Fabp7 was selectively expressed in *Mek1^DD^*- or *Etv*-rescued BG in the cerebellar cortex, suggesting that Map2k1 and ETV act cell-autonomously to promote BG formation. Furthermore, inactivation of *Fgf9* or the three FGFR genes (*Fgfr1*, *2*, and *3*) depletes BG in the mouse cerebellum as found in *Ptpn11*-cKO mutants ([@bib68]) ([Figure 8---figure supplement 3](#fig8s3){ref-type="fig"}), demonstrating the essential role of FGF signaling in BG formation. We did not attempt to rescue BG by FGF because Ptpn11 is essential to mediate FGF receptor (FGFR) signaling to ERK ([@bib33]). Collectively, these observations demonstrate that *Ptpn11* regulates the FGF-ERK-ETV cascade in the control of the aRG-to-BG transition.10.7554/eLife.23253.022Figure 9.Activation of the ERK-ETV cascade in cerebellar aRG at E13.5 is critical to BG generation.(**A**) The procedure for ex vivo electroporation. (**B--D**) Immunofluorescence of Fabp7, GFP, and Sox9 on sections of cerebellar slices 48 hr (2 day in vitro, 2 DIV) after the electroporation of *EGFP* (**B**), *Mek1^DD^* (**C**), or *Etv4* (**D**). Arrows point to the rescued BG; boxed areas are enlarged and shown in individual channels. Scale bar: 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.022](10.7554/eLife.23253.022)

Next, we examined whether the FGF-ERK-ETV cascade is important for bRG formation by *in utero* electroporation of constitutively active *FGFR1*, *FGFR1^K656E^* ([@bib87]), or *Etv4* in mouse cortex at E14.5. Similar to *Mek1^DD^*, *FGFR1^K656E^* and *Etv4* induced cells that expressed Hopx, Sox2, *Tnc, Slc1a3*, and *Ptprz1* 48 hr after electroporation ([Figure 10A](#fig10){ref-type="fig"}). Similar percentages of Hopx/Sox2 double labeling were found among *FGFR1^K656E^*-, *Mek1^DD^*-, and *Etv4*-expressing cells, and they were significantly higher than that in *GFP*- expressing cells ([Figure 10B](#fig10){ref-type="fig"}). These findings suggest that FGFR, Map2k1, and Etv4 act in the same pathway to induce bRG. Notable, *in utero* electroporation of *Mek1^DD^*, *FGFR1^K656E^*, or *Etv4* caused slightly different phenotypes, despite their similar function in inducing bRG-like cells. For example, the Hopx^+^ cells induced by *Etv4* occupied a more apical position than those induced by *FGFR1^K656E^* and *Mek1^DD^* ([Figure 10C](#fig10){ref-type="fig"}). Furthermore, *Mek1^DD^*, but not *FGFR1^K656E^* and *Etv4*, induced heterotopia near the VZ, and these heterotopia were composed of Sabt2+ cortical neurons with few Gfap+ astrocytes after birth ([Figure 5B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Taken together, our results show that activation of the FGF-ERK-ETV axis is involved in inducing the transition of aRG to BG in the cerebellum and to bRG in the neocortex.10.7554/eLife.23253.023Figure 10.Expression of activated *FGFR* or *Etv4* induces bRG in the mouse neocortex.(**A**) Immunofluorescence and in situ hybridization images of adjacent coronal sections of mouse cortices 48 hr after the *in utero* electroporation of the indicated transgene. (**B**) Quantification of Hopx/GFP double-labeled cells relative to the total number of transfected cells. Each data point represents one embryo in which three or more adjacent sections were examined. Data are presented as the mean ± SEM. *P* values were calculated using a one-way ANOVA followed by a post-hoc Turkey-Kramer multiple comparison test, *F~(9)~* =21.76. (**C**) Distribution of Hopx-positive cells induced by *Mek1^DD^*, *FGFR1^K656E^*, and *Etv4* in the upper (**U**), middle (**M**), and lower (**L**) parts of the cortex. Scale bars: 200 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.23253.023](10.7554/eLife.23253.023)

Discussion {#s3}
==========

In the present study, we investigated the similarities between bRG and BG in their genome-wide transcriptional profiles and developmental programs. Using differential gene expression and coexpression studies based on RNA-seq, we establish the molecular features of mouse nascent BG, and show the remarkably similarity between human bRG and mouse BG in their molecular characteristics. Through transcriptome analysis and immunohistochemistry, we demonstrate that heightened ERK signaling is associated with the timely formation of endogenous bRG in the mouse cortex, while stronger ERK activity in cortical aRG is linked to the abundance of bRG in the human compared to mouse cortex. We show that the activation of the FGF-ERK-ETV axis that is important for BG formation induces multipotent bRG, which display canonical human bRG gene markers and extensive proliferative capacity, in the mouse neocortex. Our results have revealed surprising parallels in the transition of aRG to bRG in the neocortex, and aRG to BG in the cerebellum.

By taking advantage of the specific loss of BG in *Ptpn11*-cKO and the rescue of BG in *Ptpn11*-cKO;*Map2k1* cerebella, we used RNA-seq to examine the transcriptome of the cerebella with and without BG at the stages before and after BG induction. Using conventional differential expression analysis and WGCNA, we identified putative markers for nascent BG. The validation of these markers was mostly carried out by inspection of expression data of Allen Mouse Brain. Because of the inherent difficulty to assign cell-type specific expression based on in situ hybridization, the gene expression analysis was performed by an examiner who was blinded to the gene symbol and the origin of the gene list. We showed that candidate gene lists that were produced by the two statistical methods were both significantly enriched in BG in P56 mouse cerebellum compared to randomly generated gene lists. One potential caveat is that BG gene expression may be dynamic during development. However, interrogation of BG-specific expression in the Allen Mouse Developmental Brain and GenePaint has revealed that many BG markers, such as *Fabp7*, *Hopx*, *Etv5*, *Ptprz1*, *Slc1a3* and *Tnc* are expressed in both nascent and mature BG ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Another caveat is that our strategy would likely identify downstream targets of the Ptpn11-ERK pathway, which may also be involved in development of non-BG cells in the cerebellum. Single-cell RNA-seq analysis will help clarify the definite markers for nascent BG.

*Ptpn11* and other components of the FGF-ERK pathway play a multifaceted roles in the progression of neural progenitors, including the timely transition from neuroepithelial cells to aRG ([@bib99]), from aRG to IPC ([@bib49]), from proliferative to neurogenic self-renewing aRG ([@bib14]), and from neurogenic to gliogenic aRG ([@bib27]; [@bib50]). After their broad expression in the cerebellar primordium at E10.5, the transcripts of *Etv4* and *Etv5* disappear, except for the region near the mid-hindbrain junction, by E12.5 ([@bib66]), but re-appear in cerebellar aRG at E14.5 ([Figure 8A](#fig8){ref-type="fig"}), following the robust expression of pERK in these cells at E13.5 ([Figure 4D](#fig4){ref-type="fig"}). While *Ptpn11* deletion does not change the transcription of *Etv4* and *Etv5* at E10.5 ([@bib66]), neither gene is expressed in the cerebellar anlage of *Ptpn11*-cKO embryos after E12.5 ([Figure 8A](#fig8){ref-type="fig"}). This suggests that activation of ERK-ETV in cerebellar aRG at E13.5 but not before is essential for BG induction. In the current study, we have extended our previous findings by showing that the expression of *Mek1^DD^*, *Etv4*, or *Etv5* cell-autonomously rescues BG in *Ptpn11*-cKO cerebella at E13.5. Coincidentally, strong ERK signaling is present in the VZ starting at E13.5 to at least E16.5, matching closely with the onset and duration of BG generation from the VZ. These results demonstrate that heightened ERK signaling activity in cerebellar aRG controls the timely aRG-to-BG transition. In parallel with the BG induction, intensified pERK in cortical aRG correlates with the formation of endogenous bRG in the mouse cortex at E17.5 ([Figure 4E--I](#fig4){ref-type="fig"}), whereas the hyperactivation of the ERK signaling induces ectopic bRG at E14.5 ([Figures 5](#fig5){ref-type="fig"} and [10](#fig10){ref-type="fig"}). Therefore, the intensification of ERK signaling controls the timely transition of aRG to BG in the cerebellum, and to bRG in the neocortex. How ERK signaling controls the formation of BG and bRG is currently unknown. Previous studies have shown that increasing the horizontal division, in which the cleavage furrow is parallel to the ventricular surface, contributes to the generation of bRG in both the human and mouse cortex ([@bib54]; [@bib77]). As it has been shown that the ERK pathway determines mitotic spindle orientation epithelial cells ([@bib115]), it is possible that ERK signaling controls the generation of BG and bRG by regulating the spindle orientation. On the other hand, the transformation of aRG into bRG resembles the epithelial-to-mesenchymal transition ([@bib42]; [@bib91]), a developmental process that is regulated by the FGF-ERK pathway ([@bib55]). Future studies will be needed to determine whether FGF-ERK signaling promotes the transition from aRG to BG or bRG similarly to the regulation of the epithelial-to-mesenchymal transition, and/or by regulating spindle orientation.

A previous study showed that *in utero* electroporation of *Mek1^DD^* or *Etv5* in E15.5 mouse neocortex enhances the generation of proliferative Fabp7^+^ cells, but no other bRG markers were examined ([@bib65]). The authors concluded that these Fabp7^+^ cells are astrocyte precursors because 20--25% of the transfectants become astrocytes at P22 and P60 ([@bib65]). Although we detected supernumerary Gfap+ cells in cortical region with *Mek1^DD^* transfection, many of the Gfap+ astrocytes were not colocalized with EGFP, which marked *Mek1^DD^* transfection, at P3 ([Figure 7B,C](#fig7){ref-type="fig"}, and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Because EGFP expression was rapidly diminished during the successive division of the induced bRG, we were uncertain whether the transfection of *Mek1^DD^* cell autonomously or non-autonomously induced astrocytes. In the current study, we showed that forced expression of *Mek1^DD^* induced neurogenic progenitor with remarkably high proliferation and self-renewing potential ([Figure 6](#fig6){ref-type="fig"}). Furthermore, these progenitors express many canonical human bRG markers ([@bib91]; [@bib117]) ([Figures 5](#fig5){ref-type="fig"} and [10](#fig10){ref-type="fig"}). Importantly, Pax6, which is not linked to astroglial lineage, was maintained in *Mek1^DD^*-induced bRG at least to E18.5 ([Figure 5D](#fig5){ref-type="fig"}). In basal progenitors (including IPCs and bRG), persistent Pax6 expression is a hallmark of the primate neocortex ([@bib81]; [@bib21]; [@bib36]; [@bib94]; [@bib4]). Indeed, sustained Pax6 expression is sufficient to expand IPC and bRG-like cells in the mouse neocortex ([@bib124]). Importantly, we show that the expression of *Mek1^DD^* primarily induced bRG, whereas IPC marker Eomes was mostly absent from *Mek1^DD^*-expressing cells ([Figure 5](#fig5){ref-type="fig"}). Although the expansion of bRG-like cells and IPC through various genetic manipulations has previously been reported, to the best of our knowledge, this is the first report of the specific induction of primate-like bRG in the mouse neocortex. Together, our data strongly suggest that activation of the FGF-ERK-ETV cascade is involved in the induction of bRG in the mouse neocortex.

In any given species, the relative abundance of bRG can be attributed, at least partially, to the bRG-forming competence of aRG and/or to the self-expansion potential of bRG. We demonstrated that FGF-ERK-ETV activity is lower in the mouse than in the human neocortical aRG ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}), and that activation of this axis is sufficient to induce bRG ([Figures 5](#fig5){ref-type="fig"}--[7](#fig7){ref-type="fig"} and [10](#fig10){ref-type="fig"}). These observations indicate that a higher level of FGF-ERK-ETV activity in aRG contributes to the greater abundance of bRG in humans than in mice. Comparative epigenetic profiling of human, rhesus macaque, and mouse corticogenesis has shown that *cis*-regulatory elements with activity in humans are enriched in the modules of coexpressed genes belonging to the FGF and TGFβ pathways ([@bib96]). In agreement with these findings, our coexpression network analysis revealed significant divergence in FGF-ERK and BMP signaling pathways in human and mouse corticogenesis ([Figure 3F](#fig3){ref-type="fig"}). Therefore, gene regulation changes that are specific to the human lineage modify corticogenesis in humans, in part by enhancing FGF-ERR signaling activity in aRG leading to expansion of bRG. Gain-of-function mutations of *FGFR2* and *FGFR3* cause Apert syndrome and thanatophoric dysplasia, which are characterized by unique and complex malformation of the cortex, including megalencephaly and polymicrogyria ([@bib38]). Moreover, mutations of the genes of the ERK signaling cascade have been implicated in neuro-cardio-facial-cutaneous (NCFC) syndromes that include an abnormal size and gyrification of the neocortex and cerebellum ([@bib100]). Our new findings imply that abnormal bRG development may contribute to the pathologies of the human neocortex that are caused by aberrant FGF-ERK function.

Despite the similarity in their generation, BG do not produce neurons during normal development ([@bib89]), unlike bRG in the human cortex. Although the *Mek1^DD^*-induced bRG possess extensive proliferative self-renewing potential, no dramatic increase in cortical neurons was observed in neocortex transfected with *Mek1^DD^*. Furthermore, both the endogenous and Mek1^DD^-induced bRG are distributed in both the SVZ and the cortical plate in the mouse cortex rather than being restricted to the outer SVZ as described in the primate cortex. Therefore, additional intrinsic and/or extrinsic factors may be required for the neurogenic potential and localization of human bRG. Comparative studies in human, ferret, and mouse have shown that the neocortical basal progenitors of humans exhibit a greater neuronal lineage commitment and degree of differentiation, partially through the activity of proneural genes ([@bib44]). In vitro and in vivo studies have shown that the forced expression of proneural genes, such as *Ascl1*, *Neurog2*, and *NeuroD1*, can reprogram glial cells to neocortical neurons ([@bib30]; [@bib78]; [@bib134]). Further studies are required to determine whether the expression of proneural genes enhances the neurogenic potential of BG in the cerebellum or *Mek1^DD^*-induced bRG in the mouse neocortex.

The expression of *Mek1^DD^* specifically expands bRG but fails to induce folding of the mouse neocortex. These findings are in agreement with the notion that an abundance of bRG is necessary, but insufficient, for gyrencephaly ([@bib39]; [@bib51]). Rather, increased neuronal output through the expansion of other basal progenitors together with bRG may be necessary for folding of the neocortex. A notable parallel may be cerebellar foliation, in which the important role played by the proliferation of granule cell precursors has been well documented. For example, functional alterations of Shh, which promotes granule cell precursor proliferation in the EGL ([@bib12]; [@bib120]; [@bib123]), have been linked to the extent of cerebellar foliation ([@bib9], [@bib10]). Interestingly, hedgehog signaling also promotes the development of BG ([@bib12]; [@bib24]) and bRG ([@bib122]). These observations suggest that the hedgehog and FGF-ERK signaling pathways act in concert to promote neuronal output via IPC or granule cell precursors as well as to expand bRG and BG populations in the evolution of a convoluted neocortical and cerebellar cortex, respectively.

Materials and methods {#s4}
=====================

Mouse and tissue preparation {#s4-1}
----------------------------

Husbandry of mice was carried out according to guidelines approved by the University of Connecticut. Light/dark cycle in the vivarium was 12 hr light on and 12 hr light off. All mouse strains were maintained on CD-1 outbred genetic background. The day of vaginal plug detection was considered embryonic day (E) 0.5. For tamoxifen administration, 4--6 milligrams of tamoxifen (Sigma, St. Louis, MI) in corn oil were administered to pregnant females through oral gavage as described ([@bib62]). Generation and characterization of the *En1^cre^* (*En1^tm2(cre)Wrst^/J*; \#007916) ([@bib63]), *Gbx2^creER^* (*Gbx2^tm1.1(cre/ERT2)Jyhl^/J*; \#022135) ([@bib8]), *Ptpn11^floxed^* ([@bib127]), *R26^Etv4DN^* ([@bib76]), and *R26^Mek1DD^* (Gt(ROSA)^26Sortm8(Map2k1\*,EGFP)Rsky^/J; \#012352) ([@bib109]) alleles have been previously reported. The *R26^Etv4DN^* allele contained the *Etv4^DN^-ires-YFP* bicistronic sequence downstream of a *loxP*-flanked *Neo-STOP* cassette. Therefore, *Etv4^DN^*-expressing cells and their progeny were permanently marked by YFP (recognized by anti-GFP antibodies) after tamoxifen-induced creER activation.

Embryonic mouse brains were dissected in cold phosphate buffered saline and fixed in 4% paraformaldehyde for 40 min to overnight. Brains were cryoprotected, frozen in Tissue-Plus (ThermoFisher Scientific, Carlsbad, CA), and sectioned in a cryostat (Leica, Germany, CM3050S).

Histochemistry, immunofluorescence, and in situ hybridization {#s4-2}
-------------------------------------------------------------

Standard protocols were used for immunofluorescence and in situ hybridization as described ([@bib8]). Detailed protocols are available on the Li Laboratory website (<http://lilab.uchc.edu/protocols/index.html>). As the antibodies for Hopx and pERK were both raised in rabbits, we used a two-step technique as described previously ([@bib104]). First we used the sensitive Tyramide Signal Amplification Kits (ThermoFisher Scientific) to detect a highly diluted anti-pERK antibody. Subsequently, conventional immunostaining was performed to detect Hopx. We confirmed that the conventional method could not detect the bound anti-pERK antibodies in the earlier steps. Primary and secondary antibodies used in the study are listed in the [Supplementary file 5A](#SD5-data){ref-type="supplementary-material"}.

To generate riboprobes for RNA in situ hybridization, PCR primers were designed using Primer 3 ([@bib118]) to amplify a 500--700 bp region of the open reading frame for a given gene; a T7 promoter sequence appended to the reverse primer enabled direct generation of antisense riboprobes from T7-mediated transcription of PCR products. Primer sequences are listed in [Supplementary file 5B](#SD5-data){ref-type="supplementary-material"} and [Supplementary file 5C](#SD5-data){ref-type="supplementary-material"}. To generate cDNA, total RNA was extracted from E13.5 mouse brain tissues using Trizol extraction kit (Invitrogen, Carlsbad, CA) and reverse transcribed with Superscript III First Strand Synthesis System using random hexamers (Invitrogen).

RNA sequencing and data analysis {#s4-3}
--------------------------------

The cerebellar anlage was microdissected from E12.5 and E13.5 brains. For E14.5 cerebellar anlage, microdissection was performed on brain slices (300 µm thickness) that were prepared with a vibratome (Leica, VT1000S). Total RNA was isolated with TRIzol (Invitrogen) or Maxwell 16 LEV RNA FFPE Kit for automated RNA isolation (Promega, Madison, WI). Approximately 500 ng of total RNA, with a RNA integrity number of at least 7.5 (mostly above 9.0), was used for library preparation with Illumina TruSeq RNA Sample Prep Kit v2 (for E12.5 and E14.5 samples) or TrueSeq Stranded mRNA LT (E13.5). For the E12.5 and E14.5 samples, eight libraries were sequenced in two lanes with HiSeq2000 (Illumina, San Diego, CA) using 50-base single end sequencing chemistry. For the E13.5 samples, 21 of them were pooled and run on NextSeq500 (Illumina) high output flow cell using 75-cycle single end sequencing chemistry. RNA-seq raw data have been deposited in the Gene Expression Omnibus under accession codes GSE87104.

For expression quantification, RNA-seq data were mapped to reference genome sequences of mouse (GRCm38) and human (GRCh38) with STAR version 2.42a ([@bib16]). Gene annotation files from GENCODE ([@bib37]) were used for mouse (vM5) and human (V22). Resulted BAM files were used to generate gene counts with *featureCount* ([@bib67]) using the uniq-counting mode.

Differential expression analysis was performed by *DESeq2* ([@bib70]). Batch effects from library preparation and sequencing were removed using the *ruv* R package ([@bib97]). Pathway and functional analysis of gene lists were performed using the Go-Elite ([@bib130]).

Comparison of gene expression in neocortical aRG of human and mouse {#s4-4}
-------------------------------------------------------------------

To examine gene expression in aRG in human and mouse neocortex, FASTQ files were obtained using the *fastq-dump* program of the SRA toolkit from the Gene Expression Omnibus, under the accession numbers GSE30765, GSE38805, GSE65000, and GSE66217. These datasets contained 13 human and 21 mouse RNA-seq samples of the VZ or aRG. Sequencing reads mapping, expression quantification and differentiation analysis were performed as described above. Orthologous genes were downloaded from Ensembl release 85. Human-mouse orthologs were defined as single-copy genes conserved in human and mouse. Because of different efficiency of mRNA enrichment among the different studies, rRNA and mitochondria genes were excluded resulting in a total 16,036 features (Ensembl ID). To assess the overall similarity between samples, we first transformed the count data into gene expression matrix using the *varianceStabilizingTransformationby* function of *DESeq2* ([@bib70]), and used the R function *dist* to determine the Euclidean distance between samples ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}) and the *plotPCA* function of *DESeq2* to show the sample relationship ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).

To perform GSEA ([@bib111]), expression matrix was generated by variance stabilizing transformation of the RNA-seq count data using the *DESeq2* package ([@bib70]). A comprehensive and monthly-updated gene-set containing all mouse pathways was downloaded from Bader lab (<http://download.baderlab.org/EM_Genesets/current_release/>) (October_01_2016 version). We added the BG-specific genes and ERK responding genes to the gene lists. GSEA was done using gene shuffling for P value estimated with 1000 permutations. Results of GSEA are listed in in [Supplementary file 4A](#SD4-data){ref-type="supplementary-material"}.

Microarray analysis {#s4-5}
-------------------

Microarray data of time course study of ERK activation ([@bib35]) were retrieved from the Gene Expression Omnibus using *GEOquery* ([@bib13]) under the accession number GSE59755. Technical sources of variation were removed with *ComBat* function of the *sva* package ([@bib59]). Differentially expressed genes with two fold changes at different time points relating to time 0 was identified with the *limma* package ([@bib98]). Results of differential gene expression analysis are shown in [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}.

Validation of gene expression in cerebellar BG {#s4-6}
----------------------------------------------

Expression data from E13.5 to P56 were automatically batch downloaded from the Image Download Service of Allen Brain Institute. BG-specific expression was manually confirmed using the following criteria. As BG are interlocked with Purkinje cells in the Purkinje cell layer (PCL), genes without any detectable signals in the PCL were scored as 0. For those with signals in PCL, genes that are specific to Purkinje cells, which were identified by their bigger, round and distinct soma, were scored as 1, those with indistinguishable between BG and Purkinje cells as 2, those that are specific to BG, which were identified by their smaller and irregular soma, as well as their radial projections around the Purkinje cells into the molecular cell layer, as 3 ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Scoring was performed by an examiner blinded to gene symbols. Fisher\'s exact test was performed to determine if BG-specific genes were significantly enriched in the bRG- and BG-specific gene lists compared with the randomly selected gene of comparable numbers.

Weighted gene Co-expression network analysis {#s4-7}
--------------------------------------------

Gene expression matrix was generated by variance stabilizing transformation of the RNA-seq count data using the *DESeq2* package ([@bib70]). Expression data were normalized for batch effect ([@bib60]) and outlier removal (Z.K less than --2) using *SampleNetwork* R function ([@bib85]). From these processed expression data, we followed the protocols of WGCNA ([@bib132]) to create a gene co-expression network. Modules were defined as branches of a hierarchical cluster tree using the top-down dynamic tree cut method ([@bib57]). For each module, the expression patterns were summarized by the module eigengene (ME), defined as the singular vector of the standardized expression patterns. Pairs of modules with high module eigengene correlations (*R* \> 0.85) were merged. The module membership (*k*~ME~) for each gene with respect to each module was then defined as the Pearson correlation between the expression level of the gene and the module eigengene ([@bib85]).

To study the preservation of human and mouse cortical coexpression networks, we combined available RNA-seq data from all cortical cell types ([@bib2]; [@bib23]; [@bib25]; [@bib45]). After careful filtering and preprocessing of the data to remove batch effects and outliers ([@bib86]), 37 human (WG13-18) and 40 mouse (E14.5) samples were included. Between the human and mouse datasets, both gene expression and connectivity were highly preserved (*R* = 0.78, p\<1 × 10^−200^ for expression; *R* = 0.33, p\<1 × 10^−200^ for connectivity), indicating that the cross-species datasets are well matched. We used the *modulePreservation* function in R ([@bib58]) to study the preservation of 11 signaling pathways (KEGG and Reactome), pan-RG signature genes ([@bib72]), early-response genes induced by ERK, and signature genes for aRG, bRG, and IPC. The complete results are shown in [Supplementary file 4B](#SD4-data){ref-type="supplementary-material"}.

In utero and ex vivo electroporation, and culture of brain slices {#s4-8}
-----------------------------------------------------------------

*In utero* electroporation was performed as described previously ([@bib103]). Briefly, 1--2 µl of plasmid DNA (1.5 µg/µl) were injected into the lateral ventricles of E14.5 brains and electroporated using four pulses at 40 V for 50 ms at 100 ms intervals through the uterine wall using a BTX ElectroSquarePorator (BTX, Holliston, MA, ECM 830).

Ex vivo electroporation was performed in E13.5 embryos. Briefly, embryos were placed in ice cold Krebs buffer containing 126 mM NaCl, 2.5 mM KCl, 1.2 mM NaH~2~PO~4~, 1.2 mM MgCl~2~, 2.5 mM CaCl~2~, 11 mM glucose, and 25 mM NaHCO~4~. *Ptpn11*-cKO embryos were identified based on truncation of the tectum ([@bib66]), and DNA solution was injected into the VI ventricle. To increase the efficiency of the experiment, both sides of the cerebellar anlagen were electroporated by rotating the orientation of the electrode using five pulses at 60 V for 50 ms at 100 ms intervals. After electroporation, brains were dissected and embedded in 4% low-melting agarose (Seakem, VWR International, Radnor, PA). Sagittal brain slices in 300 µm thickness were prepared on a vibratome (Leica, VT1000S), and kept in cold Krebs buffer on ice, and the sections were transferred to serum medium (Invitrogen, MEM with glutamine, 10% fetal calf serum, 0.5% glucose and penicillin/streptomycin antibiotics). After 15 min, the sections were transferred to polycarbonate culture membranes (Whatman™ 13mm Nuclepore™, Fisher Scientific) in Falcon organ tissue culture dishes containing 1 ml of Neurobasal/B-27 medium (Neurobasal with 1x glutamine, 1% B-27, 0.5% glucose and penicillin/streptomycin antibiotics). They were subsequently incubated at 5% CO~2~ and 37°C for 48 hr. After incubation, slices were fixed in 4% paraformaldehyde/phosphate buffered saline, washed in phosphate buffered saline, embedded in Tissue-Plus (ThermoFisher Scientific), and sectioned in a Cryostat (Leica, CM3050S). The sections were subjected to standard in situ hybridization and immunofluorescence procedures.

Expression construct {#s4-9}
--------------------

The full length cDNA for *Mek1^DD^*, *Etv4*, *Etv5*, and *FGFR1K^656E^* was cloned into the *pMES* expression vector ([@bib125]), placing upstream of an internal ribosomal entry site (*ires*) and the cDNA encoding enhance green fluorescent protein (*EGFP*). The expression cassette is under the control of cytomegalovirus early enhancer/chicken β-actin (CAG) promoters.

Pair-cell assays {#s4-10}
----------------

Pair-cell analysis was performed as described ([@bib102]). Following electroporation at E14.5 as described above, electroporated brains at E16.5 and E17.5 were sectioned using a vibratome (Leica, VT1000S). Cortical tissues that were enriched for transferred cells (marked by GFP) were dissected with tungsten needles from cortical sections. For the cortex transfected with *Mek1^DD^*, the upper and lower half of the cortex were further separated. To dissociate cells, dissected tissues were incubated in a protease solution containing 10 unit/ml papain (Fluka, Japan), 1000 units/ml DNAse I (Roche, Switzerland) and 5 mM L-cysteine in DMEM (Invitrogen), and triturated using a fire-polished Pasteur pipette to create a single-cell suspension. Cells were resuspended in culture medium containing DMEM, glutamine, penicillin/streptomycin, sodium pyruvate (Invitrogen), 1 mM N-acetyl-L-cysteine (Sigma), B27, N2 and 10 ng/ml bFGF2 (Invitrogen) and plated onto coverslips coated with poly-L-lysine (Sigma) at clonal density. The cultures were maintained in a humidified incubator at 37°C with constant 5% CO~2~ supply. In 24 or 48 hr later, the cultures were fixed and immunostained for GFP, Fabp7, and Tubb3 and counterstained with the DNA dye Hoechst 33342 solution (Invitrogen).

Quantifications and statistical analysis {#s4-11}
----------------------------------------

To determine the co-localization of markers, we divided the dorsolateral cortex into six bins paralleling to the ventricular surface with the sixth bin immediate above the ventricular zone. Images of each bin were automatically produced by ImageJ software, and the images were randomized and coded. The number of Sox2^+^ nuclei in each bin was counted with ImageJ. The numbers of GFP^+^ and GFP^+^/Hopx^+^ cells in each bin were counted manually with the examiner blinded to relevant variables, such as DNA constructs and bin numbers.

Data processing, statistical analysis and plotting were performed in R version 3.2.5. An unpaired two-tailed t-test with Welch's correction or Student\'s t-test was used for analysis of experiments involved two groups. One-way ANOVA followed by Turkey-Kramer multiple comparison test was used for analysis of experiments involving more than two groups with one comparison. Bartlett\'s test was performed to verify equal variance assumption before ANOVA and Student\'s t-test. Reproducible results were obtained from three or more samples, and quantitative data are expressed as means ± standard error of the mean (SEM).
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###### Marker genes for human neocortical aRG and bRG.

\(A\) Summary of consensus markers (first spreadsheet) based on two single-cell RNA-seq datasets ([@bib91]; [@bib117]). (B) Table listing putative BG-specific expression of the orthologs of human bRG markers (second spreadsheet). Column A and B: human and mouse gene symbol, respectively; column C: bRG markers identified by SINCERA and/or Pollen et al; column D: scores of BG specific expression; column E and F: BG-specific genes identified by differential expression analysis and WGCNA, respectively; column G: BG-specific genes identified by RNA-seq and inspection of Allen Brain Atlas. (C) BG-specific genes identified by intersecting of DE genes (third spreadsheet). Column A and B: gene symbol of mouse and human genes; column C: entrez gene ID; column D: ensembl gene ID; column D: description of gene name; column F-H: log2 fold changes. (D) BG-specific genes identified by WGCNA (fourth spreadsheet). Column A and B: gene symbol of mouse and human genes; column C: description of gene name; column D: initial assignment of co-expression module; column E: module membership value in the BG (red) module; column K and L: bRG-specific genes identified by Pollen et al and SINCERA (see [Figure 1A](#fig1){ref-type="fig"}); column M: BG-specific genes identified by differential gene expression analysis; column N: specific expression in BG of mouse cerebella at postnatal day 56 according Allen Brain Atlas. Scoring criteria: 0, no expression; 1, expressed in Purkinje cells; 2, expression in Purkinje cell layer but not sure in which cell type; 3, expressed in Bergmann glia.

**DOI:** [http://dx.doi.org/10.7554/eLife.23253.024](10.7554/eLife.23253.024)

10.7554/eLife.23253.025

###### RNA-seq analysis of microdissected cerebellar tissues of wild-type and *Ptpn11*-cKO embryos with or without *Mek1^DD^* expression at E12.5, E13.5 and E14.5.

\(A\) Summary of RNA-seq (first spreadsheet). (B) Output of STAR mapping (second spreadsheet). (C) Raw gene counts (third spreadsheet). (D) Differentially expressed genes identified by DESeq2 (third spreadsheet). Column A: ensembl gene ID B: gene symbol; column C: entrez gene ID; column D: gene symbol of the human orthologs; column E: entrez ID of human orthologs; Column F: description of gene name; Column G: the mean of normalized counts of all samples; Column H: fold changes on a logarithmic scale to base 2; columns I: Wald statistic; column K: Wald test p-value; column L: Benjamini-Hochberg adjusted p-value; column M: key of pairwise comparison.

**DOI:** [http://dx.doi.org/10.7554/eLife.23253.025](10.7554/eLife.23253.025)

10.7554/eLife.23253.026

###### Identification of early-response genes induced by ERK activation.

\(A\) List of differentially expressed genes. Column A: gene symbol; Column B: human gene symbol; column C: ensembl gene ID; column D: description of gene name; Column E: fold changes on a logarithmic scale to base 2; Column F: the mean of normalized expression of all samples; Column G: moderated t-statistic; Column H: raw p-value; Column I: adjusted p-value; column J: log odds that the gene is differentially expressed; column K: key of pairwise comparison.

**DOI:** [http://dx.doi.org/10.7554/eLife.23253.026](10.7554/eLife.23253.026)

10.7554/eLife.23253.027

###### Output of gene set enrichment analysis of gene expression in neocortical aRG between humans and mice.

\(A\) Lists of gene sets that are significantly enriched in human aRG (first spreadsheet) or mouse aRG (second spreadsheet). (B) Output of pathway preservation in human and mouse cortical coexpression networks (third spreadsheet).

**DOI:** [http://dx.doi.org/10.7554/eLife.23253.027](10.7554/eLife.23253.027)

10.7554/eLife.23253.028

###### List of antibodies, primers used in the current study.

\(A\) Lists of primary and secondary antibodies used in the current study (first spreadsheet). (B, C) Lists of primers used for RT-qPCR (second spreadsheet) and in situ hybridization (third spreadsheet). Gene name, primer names, primer sequence, and references to previously published work (if any) are listed in the first, second, third and fourth column, respectively.

**DOI:** [http://dx.doi.org/10.7554/eLife.23253.028](10.7554/eLife.23253.028)
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Analogous mechanism regulating formation of neocortical basal radial glia and cerebellar Bergmann glia\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Robb Krumlauf as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The study from Victor Li\'s group has been thoroughly reviewed by three experts in the field. The study is appreciated for both the comprehensive analysis of gene expression and the analysis of the function of the ERK pathway in genesis of bRG cells. However, there are major concerns regarding the validity of some of the markers, due to method of presentation of the validation data and/or the way in which the validation experiments were done. Since it is the use of these markers that is fundamental to much of the interpretations and the major conclusions, the authors need to address the major concerns regarding the markers. They must also address the other major criticisms raised by the reviewers, several of which cite common concerns. In addition to validation of the markers, they need to show better images of electroporated cells so that one can interpret their morphology and identity, to cite the appropriate ages for each RNA sample and age for validation, to justify use of markers that are expressed more broadly than e.g. only in bRG, etc. In addition, the authors should address the issues raised regarding proper citations throughout the manuscript, and comment more substantively regarding previous and conflicting studies, e.g. the last two major comments by reviewer \#3. Many comments can be addressed by rewriting parts of the manuscript, but others might require additional experiments, depending upon whether e.g. tissue can be re-imaged and/or restained for better presentation of marker validation.

*Reviewer \#1:*

This is a very interesting paper that explores the gene expression signatures and signaling pathways shared between Bergmann glia in the cerebellum and basal or outer radial glia in the neocortex. Both cell types are glial-like, and BG have been shown by the authors to be critical for folding of the cerebellum, and bRG have been suggested to regulate gyrification in the primate cortex. Thus, although BG do not produce neurons, the comparison is highly relevant. The authors indeed find that many bRG-specific genes also appear to be expressed in BG, and that ERK signaling regulates bRG, as they had previously shown for BG. The results are highly relevant the data in general is of high quality.

I nevertheless have several concerns that need to be addressed, mainly related to interpretation of the data and lack of clarity. One general point is that the authors use the term BG very loosely to mean what is likely a population of several cell types, some being dividing precursors and some being mature postmitotic BG, and each might be distinct at different stages. The second is that throughout the paper the authors do not clarify what age the gene expression analysis is from, and discuss whether it is relevant to mix and match early embryonic and postnatal stages. Finally, it is not clear how the authors assign their number system for expression in the BG layer, in what they think are BG cells alone, or BG and Purkinje cells. Double labeling for critical markers would be very valuable. Also, the authors should determine whether the cells in the BG layer that express the markers are dividing precursors, and whether the markers are expressed at all stages.

*Reviewer \#2:*

Heng and colleagues use previously published RNA-Seq data and novel bioinformatics to describe the gene expression typifying neocortical basal radial glia (bRG) and cerebellar Bergmann glia (BG). This study shows quite clearly that a set of genes highly enriched in nascent BG are also present in bRG and furthermore that their apical RG and EGC precursors likely share gene expression profiles. In addition, through comparative studies between mouse and human datasets, the authors demonstrate that ERK signaling is particularly enriched in aRG during their transition to bRG and BG in both mouse and human, but that ERK expression is much more highly expressed in human development. Their studies where forced higher ERK signaling in mouse aRG lead to higher production of bRG clearly support the biological significance of their findings. The study reaches some important conclusions alongside this important gene expression profiling, including that increased bRG are not sufficient to induce folding or gyrification in the mouse neocortex, as has previously been suggested. Overall, the manuscript is very well written, save for a few typographical errors that I am sure the editorial staff can identify. In fact, this is the best-crafted study I have reviewed all year, and I mean to include 2016 with that as well.

*Reviewer \#3:*

This paper by Heng and colleagues identifies molecular commonalities between bRG cells in the embryonic cerebral cortex, important for cortical folding, and Bergman Glia cells in the developing cerebellum, important for cerebellar folding. They identify the ERK pathway as potentially important to regulate the formation of these two cell types, and then perform functional experiments and additional transcriptomic meta-analyses to test their hypothesis. They conclude that activation of the FGF-ERK-Etv pathway is important for the formation of bRG and BG cells, and hence for the expansion and folding of these two tissues. The hypothesis is fascinating and the topic timely, the experiments well planned and executed, and the results nicely explained. Unfortunately, there are a number of serious concerns that lessen my initial enthusiasm for this study, including some of their key interpretations. Following is my detailed list of specific concerns and criticisms:

Introduction:

There are serious limitations in the background knowledge of this topic by the authors, which seem to ignore some of the seminal and landmark studies and discoveries.

Introduction, first paragraph -- Splitting of SVZ into ISVZ and OSVZ has never been demonstrated to result from increased proliferation of IPCs -- this sentence should be eliminated.

Introduction, first paragraph -- The concept that OSVZ may be responsible for the tangential expansion of neocortical surface area was first proposed by the original article Reillo et al. 2011 (Cerebral Cortex -- published online before the review Lui et al. 2011), and then extensively elaborated in Borrell and Reillo 2012 (Cerebral Cortex). These papers should be cited alongside with Lui et al. 2011 at this point.

Introduction, second paragraph -- A recent paper should be cited here, which is explicitly dedicated to the mechanisms of generation of bRG from aRGs: Martínez-Martínez et al. 2016 (Nat Comm).

Introduction, second paragraph -- The following papers should be added as reference to the hypothesis that bRG expansion is responsible for cortical folding, as they were seminal for this idea: Reillo et al. 2011 (Cerebral Cortex), Borrell and Reillo 2012 (Cerebral Cortex), Nonaka-Kinoshita et al. 2013 (EMBO J). These ideas were carefully reviewed and updated in Borrell and Götz 2014 (Cur Opin Neurobiol), Taverna et al. 2015 (Annu Rev Neurobiol) and Fernández et al. 2016 (EMBO J).

"However, the contribution of bRG to cortical gyrification remains unclear because bRG abundance does not correlate with either gyrification or the phylogeny of the neocortex (García-Moreno et al., 2012; Hevner and Haydar, 2012; Kelava et al., 2012)" -- This statement is absolutely incorrect. Whereas early studies, such as those cited here, showed that the mere presence of bRG in the cerebral cortex is not sufficient to drive cortical folding, several other studies by multiple labs have demonstrated that the relative abundance of bRGs DOES correlate with the degree of cortical folding, and that the phylogeny of cortical folding is much more complex than here implied: Reillo and Borrell 2012 (Cerebral Cortex), Pilz et al. 2013 (Nat Comm), Kelava et al. 2012 (Cerebral Cortex), Kelava et al. 2013 (Front Neuroanat), Lewitus et al. 2014 (PLoS Biol). Remarkably, this sentence is contradicted by the authors themselves two sentences later.

Introduction, second paragraph -- The authors should cite the following papers as knowledge on cellular and molecular mechanisms that control the transition of aRG into bRG, published before their study: LaMonica et al. 2013 (Nat Comm), Martinez-Martinez et al. 2016 (EMBO J).

Results:

Gene expression analysis in BG cells -- According to the Methods section, transcriptomic analyses were performed from bulk tissue (microdissected layers from thick tissue slices), not single cells, so the analysis contains a very noisy mixture of BG and Purkinje cells. For validation by ISH at postnatal stages, the authors indicate to have distinguished BG from Purkinje cells by morphology, allowing them to then confirm the gene expression analysis. However, there is not a single example of this. Only low power panoramic images are provided, from where it is impossible to distinguish BG from Purkinje cells. This is true throughout the manuscript when the authors assess gene expression patterns using Allen Brain Atlas, where images do not provide cell type-specific information.

In this regard, [Figure 1C](#fig1){ref-type="fig"} shows images for 1 gene only (!), at embryonic stage instead of postnatal as shown in [Figure 1B](#fig1){ref-type="fig"}, and where the control image (*Ptpn11*-cKO) is from a different embryonic stage, which clearly is not appropriate for comparison. Moreover, for a number of genes, expression is not specific to BG but clearly extended to the granule cell layer, such as Atp1a2, Cst1, Tubb2a, Tubb2b, *Fgfr1*.

In the validation by analysis of KO embryos, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, panel B shows clearly that KO embryos are completely missing ISH signal found in wt embryos. However, expression for these genes is also lost from all the surrounding tissues, not only the cerebellar anlage. How can this be interpreted as these genes being specific to BG?

Obviously, the clarity and specificity of all these analyses must necessarily be convincing, as these are the foundations for the rest of the study. It would have been much more appropriate to perform single cell RNAseq for this study. However, given that this is now out of the scope of this manuscript, it may also be of help to provide confocal images demonstrating co-expression at single cell level between BG markers and a collection of the newly identified genes (not merely 1 gene). Also, it will help the credibility of this story to add data from Purkinje cells (negative expression) in analyses like, for example, those in [Figures 1C](#fig1){ref-type="fig"}, [2E](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}.

In some of the tissue stains, it is worrisome to note that Hopx is detected at high levels in embryonic mouse cortical VZ ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, [Figure 10A and C](#fig10){ref-type="fig"}). Does this not seriously question the reliability of Hopx as a gold-standard bRG marker used in the transcriptomic analyses of this study? The same argument is also true for the identification of bRG across this study (i.e. in [Figure 5](#fig5){ref-type="fig"} and [Figure 10](#fig10){ref-type="fig"}). This has very profound consequences in the interpretation of results all along the manuscript, as well as its Discussion.

In the analysis of ERK activity, the authors first show that phosphorylated ERK is found only in the rostral-most aspect of the mouse cortex ([Figure 3](#fig3){ref-type="fig"}), but then in [Figure 4](#fig4){ref-type="fig"} they show that expression of Clu (the only ERK-early response gene expressed in mouse cortex at the same embryonic age) is lowest in the rostral aspect, graded to highest in the caudal region. How is this contradiction explained?

Induction of bRG formation by ERK activation -- Images to illustrate the Mek electroporation experiments (not the controls!) are always shown from the cortical plate (without including the IZ or SVZ), which is an abnormal layer to find bRG cells. This leads to the parsimonious conclusion that these GFP+ cells in Mek-electroporated embryos are completely abnormal and ectopic, possibly with little resemblance to bRGs. Moreover, [Figure 5C,D and E](#fig5){ref-type="fig"} are claimed to illustrate the presence of abundant bRGs, including their long basal process; however, the cells shown are (again) quite close to the pial surface, most likely already within the cortical plate, so they may well be just migrating neurons reaching the pial surface and that, by virtue of MEK overactivation, continue expressing markers of RG cells.

Overexpression of constitutively-active Mek1 by in utero electroporation has been performed previously, even at the same embryonic stages as in this study, with some very different results (Li et al. 2012, Neuron 75:1035-1050): no horizontal clusters of GFP^+^ cells, and abundant GFP^+^ astrocytes in all cortical layers. The authors need to reconcile their findings with these results published previously. In Discussion the authors make some comments regarding this paper, but not related to this question.

Overexpression of Mek1DD does not lead to cortical folding in mouse, so the authors conclude that bRG expansion itself is not sufficient to induce folding of the mouse cortex. However, it has been previously demonstrated, by several labs independently, that bRG amplification DOES lead to cortical folding in mouse (Stahl et al. 2013, Florio et al. 2015), and increased folding in ferret (Nonaka-kinoshita et al. 2013). Given my above significant concerns about the bRG identity of cells overproduced upon Mek overexpression, is it not possible that this conclusion is wrong? Definitely this reviewer is not convinced that electroporation of Mek1DD causes the overproduction of morphologically-distinguishable bRGs (though proliferative, Pax6^+^ cells are indeed present). Moreover, the authors have not checked for cell death, which may eliminate part of the overproduced bRGs and hence prevent subsequent cortical folding.

There are a lot of results presented as \"Data not shown\". I don\'t understand the need to not show many of results, given that there are almost no space limitations in *eLife*, including supplementary figures.

Figures

[Figure 1](#fig1){ref-type="fig"} -- Images in panels C and D are of insufficient resolution, not acceptable.

[Figure 4](#fig4){ref-type="fig"} -- There are two panels labeled as \"C\".

[Figure 5C](#fig5){ref-type="fig"} -- The resolution of images in insufficient to distinguish basal and apical processes in the GFP^+^ cells.

[Figure 6](#fig6){ref-type="fig"} -- The low resolution of most of images presented is unacceptable.

[Figure 9B](#fig9){ref-type="fig"} -Fabp7 protein is nearly absent in cKO embryos, so its absence from electroporated cells means bears no real additional significance. Remarkably Fabp7 expression is rescued in these mutants upon sparse electroporation of Mek1DD or Etv4, with a very significant cell non-autonomous effect. How is this explained? Is it a question of photographic exposure during image acquisition?

[Figure 9D](#fig9){ref-type="fig"} -- Panels for GFP, Fabp7 and Sox9 labeling show the exact same image, which must be replaced by the real experiment images.

10.7554/eLife.23253.044

Author response

*Reviewer \#3:*

*This paper by Heng and colleagues identifies molecular commonalities between bRG cells in the embryonic cerebral cortex, important for cortical folding, and Bergman Glia cells in the developing cerebellum, important for cerebellar folding. They identify the ERK pathway as potentially important to regulate the formation of these two cell types, and then perform functional experiments and additional transcriptomic meta-analyses to test their hypothesis. They conclude that activation of the FGF-ERK-Etv pathway is important for the formation of bRG and BG cells, and hence for the expansion and folding of these two tissues. The hypothesis is fascinating and the topic timely, the experiments well planned and executed, and the results nicely explained. Unfortunately, there are a number of serious concerns that lessen my initial enthusiasm for this study, including some of their key interpretations. Following is my detailed list of specific concerns and criticisms:*

*Introduction:*

*There are serious limitations in the background knowledge of this topic by the authors, which seem to ignore some of the seminal and landmark studies and discoveries.*

*Introduction, first paragraph -- Splitting of SVZ into ISVZ and OSVZ has never been demonstrated to result from increased proliferation of IPCs -- this sentence should be eliminated.*

Changes are made.

*Introduction, first paragraph -- The concept that OSVZ may be responsible for the tangential expansion of neocortical surface area was first proposed by the original article Reillo et al. 2011 (Cerebral Cortex -- published online before the review Lui et al. 2011), and then extensively elaborated in Borrell and Reillo 2012 (Cerebral Cortex). These papers should be cited alongside with Lui et al. 2011 at this point.*

These references are added.

*Introduction, second paragraph -- A recent paper should be cited here, which is explicitly dedicated to the mechanisms of generation of bRG from aRGs: Martínez-Martínez et al. 2016 (Nat Comm).*

This reference is added.

*Introduction, second paragraph -- The following papers should be added as reference to the hypothesis that bRG expansion is responsible for cortical folding, as they were seminal for this idea: Reillo et al. 2011 (Cerebral Cortex), Borrell and Reillo 2012 (Cerebral Cortex), Nonaka-Kinoshita et al. 2013 (EMBO J). These ideas were carefully reviewed and updated in Borrell and Götz 2014 (Cur Opin Neurobiol), Taverna et al. 2015 (Annu Rev Neurobiol) and Fernández et al. 2016 (EMBO J).*

The references are added.

*"However, the contribution of bRG to cortical gyrification remains unclear because bRG abundance does not correlate with either gyrification or the phylogeny of the neocortex (García-Moreno et al., 2012; Hevner and Haydar, 2012; Kelava et al., 2012)" -- This statement is absolutely incorrect. Whereas early studies, such as those cited, here showed that the mere presence of bRG in the cerebral cortex is not sufficient to drive cortical folding, several other studies by multiple labs have demonstrated that the relative abundance of bRGs DOES correlate with the degree of cortical folding, and that the phylogeny of cortical folding is much more complex than here implied: Reillo and Borrell 2012 (Cerebral Cortex), Pilz et al. 2013 (Nat Comm), Kelava et al. 2012 (Cerebral Cortex), Kelava et al. 2013 (Front Neuroanat), Lewitus et al. 2014 (PLoS Biol). Remarkably, this sentence is contradicted by the authors themselves two sentences later.*

In the previous experiments, the induction of bRG is associated with expansion of the IPC. Therefore, these experiments do not definitely tell us that increased generation of bRG alone is responsible for cortical folding.

*Introduction, second paragraph -- The authors should cite the following papers as knowledge on cellular and molecular mechanisms that control the transition of aRG into bRG, published before their study: LaMonica et al. 2013 (Nat Comm), Martinez-Martinez et al. 2016 (EMBO J).*

These references are added.

*Results:*

*Gene expression analysis in BG cells -- According to the Methods section, transcriptomic analyses were performed from bulk tissue (microdissected layers from thick tissue slices), not single cells, so the analysis contains a very noisy mixture of BG and Purkinje cells. For validation by ISH at postnatal stages, the authors indicate to have distinguished BG from Purkinje cells by morphology, allowing them to then confirm the gene expression analysis. However, there is not a single example of this. Only low power panoramic images are provided, from where it is impossible to distinguish BG from Purkinje cells. This is true throughout the manuscript when the authors assess gene expression patterns using Allen Brain Atlas, where images do not provide cell type-specific information.*

We add a new figure to demonstrate that the loss of Ptpn11 blocks BG formation but spare the other major cerebellar cell types ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Although we cannot rule out that transcription of some genes in non-BG lineages could be affected by Ptpn11 deletion, we expect that BG-specific genes will be greatly reduced in *Ptpn11*-cKO cerebella. We examined additional BG markers and showed that the transcripts of the genes were greatly reduced in *Ptpn11*-cKO cerebella ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

We have modified the figures with the highest available resolution of ISH images from the Allen Brain Atlas ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and [2](#fig1s2){ref-type="fig"}).

*In this regard, [Figure 1C](#fig1){ref-type="fig"} shows images for 1 gene only (!), at embryonic stage instead of postnatal as shown in [Figure 1B](#fig1){ref-type="fig"}, and where the control image (Ptpn11-cKO) is from a different embryonic stage, which clearly is not appropriate for comparison. Moreover, for a number of genes, expression is not specific to BG but clearly extended to the granule cell layer, such as Atp1a2, Cst1, Tubb2a, Tubb2b, Fgfr1.*

We have added additional stages to [Figure 1](#fig1){ref-type="fig"} and additional markers analysis in a new figure ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We have made changes to clarify that the identified BG candidate markers are highly expressed (but not exclusively) or specifically expressed in BG ([Figure 1](#fig1){ref-type="fig"} legend).

*In the validation by analysis of KO embryos, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, panel B shows clearly that KO embryos are completely missing ISH signal found in wt embryos. However, expression for these genes is also lost from all the surrounding tissues, not only the cerebellar anlage. How can this be interpreted as these genes being specific to BG?*

We have added a section to discuss the potential pitfall of our bioinformatic approach. As expected, our strategy will likely identify downstream targets of the Ptpn11-ERK pathway that are essential for BG formation (possibly other unknown aspects of cerebellar development), and some of them are not necessarily expressed or maintained in the developing BG. However, we demonstrate that the resulted gene lists are significantly enriched for genes that are expressed in the BG lineage.

*Obviously, the clarity and specificity of all these analyses must necessarily be convincing, as these are the foundations for the rest of the study. It would have been much more appropriate to perform single cell RNAseq for this study. However, given that this is now out of the scope of this manuscript, it may also be of help to provide confocal images demonstrating co-expression at single cell level between BG markers and a collection of the newly identified genes (not merely 1 gene). Also, it will help the credibility of this story to add data from Purkinje cells (negative expression) in analyses like, for example, those in [Figures 1C](#fig1){ref-type="fig"},[2E](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}.*

We have now examined additional genes ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Furthermore, we add confocal images to show that Hopx is completely colocalized with Fabp7 and Sox2 in E14.5 and E18.5 cerebella ([Figure 1C](#fig1){ref-type="fig"}). As Fabp7 and Sox2 are not expressed in Purkinje cells, we don't believe that is necessary to analyze Hopx and Purkinje cell markers.

*In some of the tissue stains, it is worrisome to note that Hopx is detected at high levels in embryonic mouse cortical VZ ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, [Figure 10A and C](#fig10){ref-type="fig"}). Does this not seriously question the reliability of Hopx as a gold-standard bRG marker used in the transcriptomic analyses of this study? The same argument is also true for the identification of bRG across this study (i.e. in [Figure 5](#fig5){ref-type="fig"} and [Figure 10](#fig10){ref-type="fig"}). This has very profound consequences in the interpretation of results all along the manuscript, as well as its Discussion.*

Identification of bRG could be ambiguous in some cases due to the limited number of specific markers. Our study is, to our knowledge, the first to take full advantage of the Pollen et al. and Thomsen et al. single-cell RNA-seq studies to characterize the molecular features of the induced bRG, and therefore will provide a richer resource for future studies regarding bRG. Regarding the specificity of Hopx, we have revised the text to indicate that Hopx is "a specific" instead of "the most specific" bRG marker (subsection "bRG-specific genes are enriched in BG", first paragraph). We also emphasize that our analyses were based on a battery of known markers, self-renewal potential, and morphology to ascertain the induction of bRG in overexpression experiments ([Figure 5A-C](#fig5){ref-type="fig"} and [Figure 10A](#fig10){ref-type="fig"}).

*In the analysis of ERK activity, the authors first show that phosphorylated ERK is found only in the rostral-most aspect of the mouse cortex ([Figure 3](#fig3){ref-type="fig"}), but then in [Figure 4](#fig4){ref-type="fig"} they show that expression of Clu (the only ERK-early response gene expressed in mouse cortex at the same embryonic age) is lowest in the rostral aspect, graded to highest in the caudal region. How is this contradiction explained?*

*Clu* is only one of the ERK-early response genes according the microarray study, but other signaling pathways can also regulate its expression. The presence of *Clu* in the caudal region does not necessarily indicate the presence of strong ERK activity in this region. Therefore, we don't believe that there is a contradiction here.

*Induction of bRG formation by ERK activation -- Images to illustrate the Mek electroporation experiments (not the controls!) are always shown from the cortical plate (without including the IZ or SVZ), which is an abnormal layer to find bRG cells. This leads to the parsimonious conclusion that these GFP+ cells in Mek-electroporated embryos are completely abnormal and ectopic, possibly with little resemblance to bRGs. Moreover, [Figure 5C,D and E](#fig5){ref-type="fig"} are claimed to illustrate the presence of abundant bRGs, including their long basal process; however, the cells shown are (again) quite close to the pial surface, most likely already within the cortical plate, so they may well be just migrating neurons reaching the pial surface and that, by virtue of MEK overactivation, continue expressing markers of RG cells.*

We have now added images to show the induced bRG in the lower layer ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Unlike primates, mice do not have the outer SVZ in the developing neocortex. It is thus difficult to predict to where the induced bRG should be confined. In the control embryos, we do find bRG-like cells that are positive for pERK, Hopx, Sox2, and Fabp7 in the cortical plates ([Figure 4G and H](#fig4){ref-type="fig"}). In the Discussion, we add a section to discuss the implication of the distribution of Mek1DD-induced bRG in the mouse cortex (Discussion, sixth paragraph).

*Overexpression of constitutively-active Mek1 by in utero electroporation has been performed previously, even at the same embryonic stages as in this study, with some very different results (Li et al. 2012, Neuron 75:1035-1050): no horizontal clusters of GFP^+^ cells, and abundant GFP^+^ astrocytes in all cortical layers. The authors need to reconcile their findings with these results published previously. In Discussion the authors make some comments regarding this paper, but not related to this question.*

We have made changes to compare these two studies (Discussion, fourth paragraph). The previous study did not examine any bRG markers except for Fabp7, and the histological data were from P22 and P60, much later than what we did in the current study. Therefore, we cannot comment on how different our results really are. However, different experimental procedure including the timing of in utero electroporation and different expression vectors could certainly contribute to any potential differences in these two studies.

*Overexpression of Mek1DD does not lead to cortical folding in mouse, so the authors conclude that bRG expansion itself is not sufficient to induce folding of the mouse cortex. However, it has been previously demonstrated, by several labs independently, that bRG amplification DOES lead to cortical folding in mouse (Stahl et al. 2013, Florio et al. 2015), and increased folding in ferret (Nonaka-kinoshita et al. 2013). Given my above significant concerns about the bRG identity of cells overproduced upon Mek overexpression, is it not possible that this conclusion is wrong? Definitely this reviewer is not convinced that electroporation of Mek1DD causes the overproduction of morphologically-distinguishable bRGs (though proliferative, Pax6^+^ cells are indeed present). Moreover, the authors have not checked for cell death, which may eliminate part of the overproduced bRGs and hence prevent subsequent cortical folding.*

We now emphasize that the manipulation in previous studies causes overproduction of both bRG and IPC, whereas activation of the FGF-ERK-ETV axis induces bRG but not IPC.

*There are a lot of results presented as \"Data not shown\". I don\'t understand the need to not show many of results, given that there are almost no space limitations in eLife, including supplementary figures.*

We have now added all the data that are essential for our conclusion (see above).

*Figures*

*[Figure 1](#fig1){ref-type="fig"} -- Images in panels C and D are of insufficient resolution, not acceptable.*

These images are replaced by high-resolution confocal images.

*[Figure 4](#fig4){ref-type="fig"} -- There are two panels labeled as \"C\".*

Correction is made.

*[Figure 5C](#fig5){ref-type="fig"} -- The resolution of images in insufficient to distinguish basal and apical processes in the GFP^+^ cells.*

For the initial submission, the quality of the many images was regrettably compromised. We now ensure high quality images are used for the resubmission. In addition, we have now included a three-dimensional reconstruction of induced bRG ([Video 1](#media1){ref-type="other"}).

*[Figure 6](#fig6){ref-type="fig"} -- The low resolution of most of images presented is unacceptable.*

Unfortunately, the confocal microscope of our facility lacks the laser to detect one of the fluorescent probes. We have to use a wide-field microscope for some of the images in this figure. To improve the clarity, we have enlarged the images and make sure that the image quality is maintained in the submission process.

*[Figure 9B](#fig9){ref-type="fig"} -Fabp7 protein is nearly absent in cKO embryos, so its absence from electroporated cells means bears no real additional significance. Remarkably Fabp7 expression is rescued in these mutants upon sparse electroporation of Mek1DD or Etv4, with a very significant cell non-autonomous effect. How is this explained? Is it a question of photographic exposure during image acquisition?*

We have presented a negative control to show the background level of Fabp7 (BLBP) expression in both control and mutant cerebella ([Figure 9B](#fig9){ref-type="fig"}). As we described in the previous publication (Li et al., 2014), Fabp7 is sporadically expressed in cells in the VZ or immediately above the VZ of *Ptpn11*-cKO cerebella after E14.5 (also see [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). However, these Fabp7^+^ cells lack the characteristic BG morphology in the mutants as they extend their cellular processes parallel, instead of perpendicular, to the VZ. Here, we show that the rescued BG identified by molecular markers and morphology were mostly derived from GFP^+^ cells, suggesting that Mek1DD, Etv4 and Etv5 likely act cell-autonomously.

*[Figure 9D](#fig9){ref-type="fig"} -- Panels for GFP, Fabp7 and Sox9 labeling show the exact same image, which must be replaced by the real experiment images.*

We have corrected the mistake.

[^1]: Department of Genetics, Yale University, New Haven, United States.
